Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1050.Time spend outdoors in summer,49483,0.183725417748104,0.0403036492161446,0.104730265284461,0.262720570211748,5.18048941756379e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1060.Time spent outdoors in winter,47374,0.0416461348758639,0.0444664797224577,-0.0455081653801532,0.128800435131881,0.348989940090274
EPHA2,Ephrin type-A receptor 2,Physical activities,X1070.Time spent watching television (TV),50274,0.226962513189869,0.0397519935878641,0.149048605757655,0.304876420622082,1.14815097427637e-08
EPHA2,Ephrin type-A receptor 2,Physical activities,X1080.Time spent using computer,47410,-0.0654738258649915,0.0388835996570589,-0.141685681192827,0.0107380294628439,0.0922288625942389
EPHA2,Ephrin type-A receptor 2,Physical activities,X1090.Time spent driving,44760,-0.176661614982236,0.0425715201036724,-0.260101794385434,-0.0932214355790379,3.34527247309583e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1160.Sleep duration,51288,0.14929221422295,0.0361716701915596,0.0783957406474933,0.220188687798407,3.68318949610093e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35731,0.00336685488174999,0.012068054110503,-0.0202865311748358,0.0270202409383358,0.780261322748923
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35731,0.00762864690668103,0.0133064576531626,-0.0184520100935176,0.0337093039068797,0.566456878895291
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35731,0.0111364038688412,0.0142417884944457,-0.0167775015802724,0.0390503093179547,0.434268379274696
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35731,0.0259607643213506,0.0144548607000744,-0.00237076265079516,0.0542922912934964,0.0725386534300817
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35731,0.0445512608122145,0.0147917054840876,0.0155595180634027,0.0735430035610263,0.00260521334941042
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35731,-0.0308409347404602,0.038593852487872,-0.106484885616689,0.0448030161357689,0.42425022297966
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35731,0.0393987934209935,0.0461918867224683,-0.0511373045550444,0.129934891397031,0.393722598955771
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35731,0.0255483625418544,0.0235898811803519,-0.0206878045716354,0.0717845296553442,0.278835234168946
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35731,0.0330420741783068,0.018066066061818,-0.00236741530285636,0.06845156365947,0.0674476569766486
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35731,0.032973579642419,0.0121598624530572,0.00914024923442681,0.0568069100504112,0.0067104896176884
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35731,0.0348184268073765,0.0191915556779364,-0.0027970223213788,0.0724338759361317,0.0696800724701896
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35731,0.0132784096025999,0.00911970230352327,-0.00459620691230568,0.0311530261175055,0.145432913384326
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35731,0.0170017831574701,0.0124022137664221,-0.00730655582471722,0.0413101221396575,0.170459624348094
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35731,0.0043508686392148,0.0196110269302955,-0.0340867441441643,0.0427884814225939,0.824430564418011
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35731,0.0206380419263971,0.0181293346416342,-0.0148954539712059,0.0561715378240002,0.255000776319763
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35731,0.0270632058495488,0.0223214694469209,-0.0166868742664161,0.0708132859655138,0.225388217999214
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35731,0.0246334566949702,0.0218769032572153,-0.0182452736891719,0.0675121870791122,0.260202181023927
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35731,0.0089714149743523,0.0139654150532495,-0.0184007985300167,0.0363436284787214,0.520632648103503
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35731,0.0208158923165655,0.0136634840853406,-0.00596453649070219,0.0475963211238331,0.127685792550365
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35731,-0.00955059726783362,0.0151510257006107,-0.0392466076410305,0.0201454131053633,0.528479416343108
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120040.Fatigue severity over the past week,35736,0.320562388811615,0.0727984087563227,0.177877507649223,0.463247269974008,1.08109356090122e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35739,0.246583165627156,0.0722537762043918,0.104965764266548,0.388200566987764,0.00064671257328656
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35739,0.0995041195040239,0.0789991772045483,-0.0553342678168908,0.254342506824939,0.207869705740202
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120098.Mobility problems today,35741,0.551857774522213,0.0830005171855938,0.389176760838449,0.714538788205977,3.17203192164906e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120099.Self-care problems today,35741,0.424447438510729,0.121736830253315,0.185843251214231,0.663051625807227,0.000492149419164927
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120100.Problems doing usual activities,35741,0.32092219307348,0.0799466345499011,0.164226789355674,0.477617596791286,6.02570415294787e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120101.Pain or discomfort today,35741,0.199242449674945,0.0732212122604354,0.0557288736444913,0.342756025705398,0.00652222564839468
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120102.Anxiety or depression today,35741,0.291603733982751,0.0913194268899102,0.112617657278528,0.470589810686975,0.00141302817188535
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120103.Scale to indicate how health is today,35724,-0.0190819194948067,0.00396737159040094,-0.0268579678119925,-0.0113058711776208,1.54251948063398e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35725,0.381707241729091,0.0893459825931406,0.206589115846536,0.556825367611647,1.96039479883135e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35724,0.321566909875073,0.0949124659599911,0.13553847659349,0.507595343156655,0.000707764010634753
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35729,0.16931780838823,0.0737232760998362,0.0248201872325506,0.313815429543909,0.0216666435198965
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35734,0.288054366584809,0.074537751246501,0.141960374141667,0.434148359027951,0.000112284466177072
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35733,0.549890168873812,0.104066201360894,0.345920414206458,0.753859923541165,1.3010681373253e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35718,0.240049302301467,0.100256225231985,0.043547100846776,0.436551503756158,0.0166752049484112
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35736,0.302648849585424,0.0952289227862163,0.11600016092444,0.489297538246408,0.00148866749834754
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35729,0.332414623203434,0.135689709441494,0.0664627926981063,0.598366453708761,0.0143168706304624
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35694,0.399287749987959,0.190058561484231,0.0267729694788661,0.771802530497053,0.0356878550039662
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33049,0.355762375475042,0.0998745313668274,0.16000829399606,0.551516456954024,0.00037176527867445
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48857,0.274011648965078,0.0814289820896129,0.114410844069437,0.433612453860719,0.000766750632393829
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47683,0.108432280618637,0.0491485562324076,0.0121011104031176,0.204763450834156,0.0273808210011117
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1289.Cooked vegetable intake,50394,-0.177005540274221,0.0372443711418961,-0.250004507712338,-0.104006572836105,2.02153471526666e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49592,-0.200354148847761,0.0385965401749565,-0.276003367590676,-0.124704930104846,2.1113063130302e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1309.Fresh fruit intake,50238,-0.0195752441178146,0.0393919592920545,-0.0967834843302414,0.0576329960946122,0.619239923228384
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1319.Dried fruit intake,49290,-0.129193387572225,0.0420799574256943,-0.211670104126586,-0.0467166710178641,0.0021420110808255
EPHA2,Ephrin type-A receptor 2,Health and medical history,X134.Number of self-reported cancers,51432,0.557461733584002,0.0690874266517752,0.422050377346523,0.692873089821481,7.43840551881196e-16
EPHA2,Ephrin type-A receptor 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51433,0.46681549678359,0.0388590119740837,0.390651833314386,0.542979160252794,3.81970152259764e-33
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X136.Number of operations, self-reported",51433,0.285230033581435,0.0360638561738324,0.214544875480723,0.355915191682146,2.71109481995179e-15
EPHA2,Ephrin type-A receptor 2,Health and medical history,X137.Number of treatments or medications taken,51433,0.567065936898617,0.0379114830143747,0.492759430190443,0.641372443606792,2.40576447020466e-50
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1438.Bread intake,50918,0.0141556081497223,0.00236461306685527,0.00952096653868598,0.0187902497607586,2.17764395083198e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1458.Cereal intake,50268,0.241572469254497,0.0374642674174761,0.168142505116244,0.31500243339275,1.15667376467343e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1488.Tea intake,50603,0.00769614349035743,0.00233894344430921,0.00311181433951138,0.0122804726412035,0.00100189571027482
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1498.Coffee intake,49685,-0.193697465975996,0.0371529356572145,-0.266517219864137,-0.120877712087856,1.87041082488744e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1528.Water intake,49374,0.0543012018297867,0.0374523246475857,-0.0191053544794813,0.127707758139055,0.147108383085245
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1568.Average weekly red wine intake,45958,-0.55571257116549,0.0429425440616437,-0.639879957526311,-0.471545184804668,3.97351733065574e-38
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,45948,-0.221872757024971,0.0448133781709042,-0.309706978239943,-0.134038535809999,7.45117240434129e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46020,-0.148597938203685,0.043803206410649,-0.234452222768557,-0.0627436536388133,0.000694376757720831
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1598.Average weekly spirits intake,45948,-0.0440113321829967,0.0457301416560305,-0.133642409828817,0.0456197454628232,0.33585505907409
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1608.Average weekly fortified wine intake,45990,-0.000846255311876977,0.0811304249017776,-0.159861888119361,0.158169377495607,0.991677695551915
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1737.Childhood sunburn occasions,45434,-0.146908178083329,0.0436852613247058,-0.232531290279752,-0.0612850658869053,0.000773064970954198
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1807.Father's age at death,45590,-0.00846731180094802,0.00274873550982204,-0.0138548334001992,-0.00307979020169683,0.00207025894489799
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1845.Mother's age,36980,-0.011334607327818,0.00580437948011686,-0.0227111911088471,4.19764532110199e-05,0.0508803182558371
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1873.Number of full brothers,51038,-0.00644449782097659,0.0358468153780369,-0.0767042559619289,0.0638152603199757,0.857327842993854
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1883.Number of full sisters,51040,0.0230727057598234,0.0359342854341818,-0.0473584936911729,0.0935039052108196,0.520827443124531
EPHA2,Ephrin type-A receptor 2,Physical measures,X20015.Sitting height,51244,-0.00106993156716471,0.00307038146934001,-0.00708787924707113,0.00494801611274171,0.727491522417847
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20016.Fluid intelligence score,35933,-0.194778158060723,0.0594570574010075,-0.311313990566698,-0.0782423255547483,0.00105798420679716
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20018.Prospective memory result,36270,0.313736299747297,0.0747532998185336,0.167219832102972,0.460252767391623,2.73580074464011e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35852,0.0125294252899356,0.00418942709244481,0.00431814818874373,0.0207407023911274,0.00279251003623669
EPHA2,Ephrin type-A receptor 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35856,0.0151228429889653,0.00420187305474153,0.00688717180167192,0.0233585141762587,0.000321484164581183
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20023.Mean time to correctly identify matches,51138,0.0118238677000665,0.00240741299676777,0.00710533822640168,0.0165423971737314,9.10422785732556e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48107,-0.00817127914952415,0.00533217771776194,-0.0186223474763375,0.00227978917728925,0.125428411112714
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47673,-0.0164911838227276,0.0119815621274011,-0.0399750455924339,0.00699267794697861,0.168720139965253
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47636,-0.0133411070961035,0.0156511652764484,-0.0440173910379423,0.0173351768457353,0.39400093643485
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47658,0.00209293321927368,0.0142328605850339,-0.0258034735273928,0.0299893399659401,0.883094605625803
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47679,-0.00775100346967029,0.00945316531919715,-0.0262792074952967,0.0107772005559561,0.41226205715274
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#2.Illnesses of father_Stroke,47851,-0.0105993595214532,0.00677684611387068,-0.0238819779046398,0.00268325886173331,0.117821107944037
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,47795,0.00218978279421397,0.00857852290881339,-0.0146241221070603,0.0190036876954882,0.798522412961675
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47695,-0.00407254714841092,0.0104675077839005,-0.0245888624048559,0.0164437681080341,0.697231961590526
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,47817,0.0271716971251926,0.00806216251562927,0.0113698585945593,0.042973535655826,0.000752412272446821
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,47907,0.00166273431416401,0.00603033578199215,-0.0101567238185406,0.0134821924468686,0.782759698300526
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,47761,0.00138557644318115,0.00826966588961709,-0.0148229687004684,0.0175941215868306,0.866939655512554
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,48859,-0.000290972661313061,0.00637103326761648,-0.0127781978658414,0.0121962525432152,0.963572778229512
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,48708,-0.0206346223321518,0.00892010685647389,-0.0381180317708406,-0.00315121289346298,0.020717794959067
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,48629,0.00974862888886688,0.019779072938657,-0.0290183540709008,0.0485156118486345,0.62210566171793
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,48662,0.019884911111528,0.0106428183095206,-0.000975012775132469,0.0407448349981884,0.0617226102975312
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,48805,6.77620709588543e-05,0.00717234096869447,-0.0139900262276823,0.0141255503696,0.992462037546913
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,48699,0.0137982165264787,0.011956743728187,-0.0096370011807679,0.0372334342337253,0.248509286885663
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,48670,0.00526090420626227,0.0109250329278964,-0.0161521603324146,0.0266739687449391,0.630133855544926
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,48677,-0.0108076824863683,0.00908666525297778,-0.0286175463822047,0.00700218140946816,0.234296244110932
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,48713,0.0274291387262248,0.0108966324117693,0.00607173919915694,0.0487865382532927,0.0118364560088715
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,48907,-0.0029396677007318,0.00548500233558571,-0.0136902722784798,0.00781093687701619,0.592001409035908
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,48762,0.0119704895605639,0.00826878455256209,-0.00423632816245776,0.0281773072835856,0.147724295695359
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45913,-0.00693007676947173,0.00871914815487168,-0.0240196071530202,0.0101594536140768,0.426734219422326
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45772,0.0291315082914104,0.0345786989383181,-0.0386427416276931,0.0969057582105139,0.399536791247784
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45764,0.0125171184455385,0.0345543477717281,-0.0552094031870485,0.0802436400781255,0.717173874172943
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45818,-0.0124471600687748,0.0113860269796211,-0.0347637729488322,0.00986945281128253,0.274323011841285
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45778,-0.000463838685470184,0.0203553666032809,-0.0403603572279008,0.0394326798569604,0.981820405402796
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45812,0.0160553784291757,0.0145609607713864,-0.0124841046827417,0.0445948615410931,0.270202510244253
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45786,0.0131477588072894,0.0166823023689997,-0.0195495538359501,0.0458450714505288,0.430633788465329
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45789,0.0312325902095075,0.016120727642215,-0.000364035969233942,0.0628292163882489,0.0527106113186176
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45791,-0.000245362626395483,0.0128434809500376,-0.0254185852884691,0.0249278600356782,0.984758314584045
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45813,0.0392996438868523,0.0162009149368805,0.00754585061056655,0.071053437163138,0.0152862865258867
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45980,0.0077609793744078,0.00663831977210894,-0.00525012737892572,0.0207720861277413,0.242372112309334
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45877,0.027863546096496,0.0092110614694383,0.00980986561639693,0.0459172265765951,0.00248990920790066
EPHA2,Ephrin type-A receptor 2,Mental health,X20127.Neuroticism score,47003,0.132916786673568,0.0374460246150079,0.0595225784281524,0.206310994918983,0.00038684283925019
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35933,-0.0816789727554972,0.0601627694106939,-0.199598000800457,0.0362400552894628,0.174621943904245
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20161.Pack years of smoking,36552,0.0202846525935107,0.00422589946275495,0.0120018896465109,0.0285674155405104,1.61496631955803e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36552,0.0198732127534179,0.00416390190389921,0.0117119650217755,0.0280344604850604,1.84981535990358e-06
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20191.Fluid intelligence score,34049,-0.11689679356392,0.0719092601817737,-0.257838943520197,0.0240453563923562,0.10408947529186
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34050,-0.0997955932156241,0.074064351582059,-0.24496172231646,0.0453705358852115,0.177901988501697
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20240.Maximum digits remembered correctly,33526,-0.153866665726039,0.0764974984492045,-0.303801762686479,-0.00393156876559775,0.044338234277089
EPHA2,Ephrin type-A receptor 2,Physical measures,X20255.Spirometry QC measure,44887,0.0561208285850092,0.0466789715167933,-0.0353699555879057,0.147611612757924,0.229275570877036
EPHA2,Ephrin type-A receptor 2,Eye measures,X20261.avMSE,33651,0.00721428128745033,0.0051174560488092,-0.0028159325682157,0.0172444951431164,0.158678106931997
EPHA2,Ephrin type-A receptor 2,Eye measures,X20262.Myopia diagnosis,33651,0.0326834638009319,0.0908044278320065,-0.145293214749801,0.210660142351665,0.718912670916713
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20280.Glucose-lactate,41589,0.00825594083516336,0.00307089333004625,0.00223698990827271,0.014274891762054,0.00718763125999676
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,41612,0.0148184635226716,0.0032523234143507,0.00844390963054422,0.021193017414799,5.25436148815186e-06
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35641,-0.00996889765412117,0.0199823500148253,-0.0491343036831788,0.0291965083749365,0.617875882532966
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35641,-0.0188807964216182,0.0447898824009184,-0.106668965927418,0.0689073730841819,0.673372546161903
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35642,-0.0100516686039275,0.0524784609528899,-0.112909452071592,0.0928061148637368,0.848108900446213
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35642,-0.0121869378114926,0.0194047801927889,-0.0502203069893589,0.0258464313663737,0.529999464612945
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35642,-0.0414501680407856,0.027600240304098,-0.0955466390368176,0.0126463029552464,0.13319241497285
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35644,0.0257651782630606,0.0383086092500257,-0.0493196958669897,0.100850052393111,0.501243669385394
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35644,-0.0198634130015011,0.0233611300689623,-0.0656512279366672,0.025924401933665,0.39520044280693
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35644,0.0131107195112139,0.0265694180783604,-0.0389653399223726,0.0651867789448003,0.621708976747819
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35644,0.0165190292120004,0.0397642468749677,-0.0614188946629362,0.094456953086937,0.677844070262235
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35644,0.00723907812360335,0.0444558977287098,-0.0798944814246679,0.0943726376718746,0.870651214206185
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35644,0.00952895775634816,0.0283183121519921,-0.0459749340615563,0.0650328495742526,0.736507982995136
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35644,0.0479793800653102,0.0428196908453394,-0.035947213991555,0.131905974122175,0.262539783927365
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35644,0.0258960283044935,0.0350626313379783,-0.042826729117944,0.094618785726931,0.460195859779119
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35647,-0.0417148050035064,0.0578224355279372,-0.155046778638263,0.0716171686312505,0.470669297088303
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35647,-0.0266703867867436,0.0253881226325638,-0.0764311071465686,0.0230903335730813,0.293521346164881
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35647,-0.0502130037829032,0.0335342531259783,-0.115940139909821,0.0155141323440143,0.134343199084489
EPHA2,Ephrin type-A receptor 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35647,0.160139480726657,0.0690053655316924,0.0248889642845397,0.295389997168774,0.0203324360198048
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20600.Liking for adding salt to foods,36296,-0.00399480354326595,0.0642733197760977,-0.129970510304417,0.121980903217885,0.950442310445335
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20601.Liking for aniseed,36296,-0.0334758406632516,0.0636709300941572,-0.1582708636478,0.0913191823212965,0.599067817256058
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20602.Liking for apple juice,36296,0.204151282929873,0.0652282056935641,0.076303999770487,0.331998566089258,0.0017557995468393
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20603.Liking for apples,36296,0.10382626639146,0.0658897151036871,-0.0253175752117669,0.232970107994687,0.115122663609331
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20604.Liking for asparagus,36296,-0.49473136686492,0.0641285794923238,-0.620423382669874,-0.369039351059965,1.36537894660789e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20605.Liking for aubergine,36296,-0.473725848294249,0.063233815122658,-0.597664125934658,-0.349787570653839,7.55829233070986e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20606.Liking for avocados,36296,-0.407486926876649,0.063601973920284,-0.532146795760405,-0.282827057992892,1.57330401506483e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20607.Liking for bacon,36296,-0.0198584574088459,0.0644181582642648,-0.146118047606805,0.106401132789113,0.75788203491583
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20608.Liking for baked or steamed fish,36296,-0.256832020560259,0.0641111776944216,-0.382489928841326,-0.131174112279193,6.23271342916761e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20609.Liking for bananas,36296,0.142869855088959,0.0660073093496839,0.0134955287635782,0.272244181414339,0.0304601275605474
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36296,-0.190745106947286,0.064181717255012,-0.31654127276711,-0.0649489411274626,0.00296827781166102
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20611.Liking for beef steak,36296,-0.0870083687732256,0.0649805430408563,-0.214370233133304,0.0403534955868528,0.180613163464496
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20612.Liking for beetroot,36296,-0.137908238488697,0.064492236088515,-0.264313021222186,-0.0115034557552074,0.0325181886776166
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20613.Liking for bell pepper,36296,-0.222926140806331,0.0641608757028773,-0.348681457183971,-0.097170824428692,0.000514653716856758
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20614.Liking for bicycling,36296,-0.148633423659851,0.0640495744922361,-0.274170589664634,-0.0230962576550687,0.0203344960467517
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20615.Liking for biscuits,36296,0.301889619516506,0.0648774005767393,0.174729914386097,0.429049324646915,3.32241963440012e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20616.Liking for bitter foods,36296,-0.342383826197364,0.0638304168657921,-0.467491443254317,-0.217276209140411,8.37871855594059e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20617.Liking for bitter or ale,36296,-0.591414593201112,0.0638691424634307,-0.716598112429436,-0.466231073972788,2.61150713659218e-20
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20618.Liking for black olives,36296,-0.478198456563906,0.0639410655059732,-0.603522944955614,-0.352873968172199,8.33348148854796e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20619.Liking for black pepper,36296,-0.297833971808973,0.0643796438343774,-0.424018073724353,-0.171649869893593,3.78507235178369e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20620.Liking for blue cheese,36296,-0.273731490135532,0.0632360276416205,-0.397674104313109,-0.149788875957956,1.51874686915111e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20621.Liking for bolognese sauce,36296,-0.156364594138684,0.0647553934311071,-0.283285165263654,-0.0294440230137138,0.0157715414445786
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20622.Liking for broad beans,36296,-0.194391975024301,0.0641594433713623,-0.320144484032172,-0.0686394660164314,0.00245507724221215
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20623.Liking for broccoli,36296,-0.207922976901691,0.0650682326384187,-0.335456712872991,-0.0803892409303899,0.00140172134728048
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20624.Liking for brown rice,36296,-0.0674978103131861,0.0634885178486304,-0.191935305296502,0.0569396846701295,0.287747382569454
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20625.Liking for brussel sprouts,36296,-0.137594594354821,0.0635608311432187,-0.262173823395529,-0.0130153653141119,0.030435963394955
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20626.Liking for burgers (meat),36296,0.0835450695227243,0.0631484478731131,-0.0402258883085773,0.207316027354026,0.185876452522881
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20627.Liking for burn of spicy foods,36296,-0.300919433528603,0.0643125575393264,-0.426972046305683,-0.174866820751523,2.93185778899055e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20628.Liking for butter on bread,36296,0.150781517520702,0.0646260171517195,0.0241145239033318,0.277448511138072,0.01966647986317
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20629.Liking for butternut squash,36296,-0.298457274314292,0.0630915460260299,-0.42211670452531,-0.174797844103273,2.27915189686212e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20630.Liking for cabbage,36296,-0.16510727150763,0.0648354791753145,-0.292184810691246,-0.0380297323240133,0.0108984606254344
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20631.Liking for cake,36296,0.433175538271636,0.0644438966332481,0.306865500870469,0.559485575672802,1.92392875933001e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20632.Liking for cake icing,36296,0.311862137904578,0.0632612923823948,0.187870004835084,0.435854270974072,8.40602953766739e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20633.Liking for capers,36296,-0.52587560243826,0.0635189230749143,-0.650372691665092,-0.401378513211427,1.45181259190225e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20634.Liking for cauliflower,36296,-0.143108512578006,0.0645707113389954,-0.269667106802437,-0.0165499183535751,0.0266996603087134
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20635.Liking for cereal or granola bar,36296,0.116859000694286,0.0637626977878585,-0.00811588696991705,0.241833888358488,0.0668832774694589
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20636.Liking for cheesecake,36296,0.241316885832525,0.0634025610625251,0.117047866149975,0.365585905515074,0.000142268254707163
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20637.Liking for cherries,36296,-0.0471657465722932,0.0657310280220735,-0.175998561495557,0.0816670683509707,0.473052402485818
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20638.Liking for chicken,36296,0.027505794925285,0.0662369158758582,-0.102318560191397,0.157330150041967,0.677960371457689
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20639.Liking for chilli pepper,36296,-0.333170106889577,0.0638066426982676,-0.458231126578181,-0.208109087200972,1.82072497985918e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20640.Liking for chips or french fries,36296,0.186643004737752,0.0644842318540624,0.0602539103037897,0.313032099171714,0.00380955671909745
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20641.Liking for cigarette smoking,36296,-0.0318600824686456,0.100568228676296,-0.228973810674185,0.165253645736894,0.751403456837556
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20642.Liking for cod,36296,-0.167882422503485,0.0662517692425842,-0.29773589021895,-0.0380289547880205,0.0112963481984563
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20643.Liking for coffee with sugar,36296,0.2117792229272,0.0661406207477652,0.0821436062615798,0.341414839592819,0.00137054706431285
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20644.Liking for coffee without sugar,36296,-0.282663569770058,0.0639571296593031,-0.408019543902292,-0.157307595637824,1.00250951749212e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20645.Liking for coriander,36296,-0.362359085146006,0.0635856645850206,-0.486986987732647,-0.237731182559366,1.25145614424712e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20646.Liking for corn flakes,36296,0.34121809284985,0.0633261029146813,0.217098931137074,0.465337254562625,7.32476983374505e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20647.Liking for cream,36296,0.210732810878951,0.0636087435677928,0.0860596734860771,0.335405948271825,0.000927428074866165
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20648.Liking for croissant,36296,0.120594576511533,0.0642901709472587,-0.00541415854509379,0.24660331156816,0.0607225948375626
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20649.Liking for cucumber,36296,-0.019577329069394,0.0644062946648472,-0.145813666612495,0.106659008473707,0.761161958893036
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20650.Liking for curry,36296,-0.248213155847188,0.0654781912662383,-0.376550410729015,-0.11987590096536,0.000151326171809616
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20651.Liking for dairy products,36296,0.241536892954163,0.0656173503337647,0.112926886299984,0.370146899608342,0.000233919898486408
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20652.Liking for dark chocolate,36296,-0.058201118203623,0.0651593816401351,-0.185913506218288,0.0695112698110418,0.371771807125875
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36296,0.270439605315737,0.0653946978524802,0.142265997524876,0.398613213106599,3.57956496313275e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20654.Liking for dried fruit,36296,-0.0486481175111006,0.0649070450751243,-0.175865925858344,0.078569690836143,0.45357616834509
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20655.Liking for eggs,36296,-0.00784340915027839,0.065486373695803,-0.136196701594052,0.120509883293495,0.904667192982096
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20656.Liking for exercising alone,36296,-0.257205489727962,0.0643114465814794,-0.383255925027661,-0.131155054428262,6.4105531908505e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20657.Liking for exercising with others,36296,-0.106103958028248,0.0631159848503642,-0.229811288334962,0.0176033722784662,0.0927851144199276
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36296,-0.363443459204361,0.0644633530368858,-0.489791631156658,-0.237095287252065,1.78145027829355e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20659.Liking for fatty foods,36296,0.106461609704948,0.062925900220254,-0.0168731547267494,0.229796374136646,0.0907138184934771
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20660.Liking for fresh tomatoes,36296,-0.206876637239471,0.0665209007527855,-0.337257602714931,-0.0764956717640115,0.00187803848827012
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20661.Liking for fried chicken,36296,0.0018462955790418,0.0631204854915073,-0.121869855984312,0.125562447142396,0.976665693251982
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20662.Liking for fried or battered fish,36296,-0.073101031170493,0.063771845332295,-0.198093848021791,0.0518917856808051,0.251710843293274
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20663.Liking for fruit,36296,-0.0108806676217024,0.0679842516360826,-0.144129800828424,0.12236846558502,0.872848347453609
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20664.Liking for garlic,36296,-0.350174878538343,0.064582974129269,-0.47675750783171,-0.223592249244975,6.06944272398651e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20665.Liking for gherkins,36296,-0.252364890142871,0.0635033650827808,-0.376831485705122,-0.127898294580621,7.13101608064157e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20666.Liking for globe artichoke,36296,-0.39220544886557,0.0633425062705779,-0.516356761155902,-0.268054136575237,6.25289877100608e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20667.Liking for goat's cheese,36296,-0.359615582058876,0.0628090664480402,-0.482721352297035,-0.236509811820717,1.06988942313598e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20668.Liking for going to a cafe,36296,0.0822519421928807,0.0630689685725724,-0.0413632362093613,0.205867120595123,0.192218536837932
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20669.Liking for going to the gym,36296,-0.162114660349596,0.0632005989716158,-0.285987834333963,-0.0382414863652292,0.010333975303114
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20670.Liking for going to the pub,36296,-0.53081681866712,0.06315138695287,-0.654593537094745,-0.407040100239495,5.03070573044075e-17
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20671.Liking for grapefruit,36296,0.0247358677280948,0.0634348710220774,-0.0995964794751769,0.149068214931367,0.696590854331072
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20672.Liking for green olives,36296,-0.488127953467767,0.0638644684462252,-0.613302311622369,-0.362953595313166,2.37546343981278e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20673.Liking for haddock,36296,-0.278258783379419,0.0659398286561687,-0.40750084754551,-0.149016719213328,2.47232444663296e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20674.Liking for ham,36296,-0.0115846819145428,0.064885149127206,-0.138759574203867,0.115590210374781,0.8583025577318
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20675.Liking for hard cheese,36296,-0.0153320043518727,0.0654892742648392,-0.143690981910957,0.113026973207212,0.81490213851638
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20676.Liking for herring,36296,-0.26212591394019,0.0636039947309634,-0.386789743612878,-0.137462084267501,3.80833805795747e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20677.Liking for honey,36296,0.0803917335681739,0.0641567895420948,-0.0453555739343318,0.20613904107068,0.210225236443134
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36296,-0.345480108553044,0.063073551527651,-0.46910426954724,-0.221855947558848,4.45222814399619e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20679.Liking for ice cream,36296,0.315749958079816,0.0649766454352406,0.188395733026745,0.443104183132888,1.20050639684462e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20680.Liking for jam,36296,0.252595045029107,0.0642411988884358,0.126682295207772,0.378507794850441,8.49895674840029e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20681.Liking for kiwi fruit,36296,-0.139827006904862,0.0643360930846089,-0.265925749350696,-0.0137282644590291,0.0297818888526319
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20682.Liking for lager,36296,-0.303309354985158,0.0640310546984869,-0.428810222194193,-0.177808487776124,2.2089319853712e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20683.Liking for lamb,36296,-0.111633906425448,0.0650521265337977,-0.239136074431691,0.0158682615807955,0.0861897941493201
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20684.Liking for lemons,36296,-0.22038095168732,0.0636857866005213,-0.345205093424342,-0.0955568099502979,0.000542219724827718
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20685.Liking for lentils or beans,36296,-0.194014342488591,0.0645025813284761,-0.320439401892404,-0.0675892830847776,0.00263951151448455
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20686.Liking for liver,36296,-0.178722779106036,0.0639852712211453,-0.304133910699481,-0.0533116475125911,0.00523207245295435
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20687.Liking for mackerel,36296,-0.34904976992685,0.0641136227252467,-0.474712470468334,-0.223387069385367,5.36336149260503e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20688.Liking for marzipan,36296,0.165870585854549,0.0636534842724192,0.0411097566806071,0.29063141502849,0.00918268656932429
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20689.Liking for mayonnaise,36296,-0.1233014304927,0.0639272292279382,-0.248598799779459,0.00199593879405917,0.0537952088130681
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20690.Liking for melon,36296,-0.0499024891967458,0.064627891171275,-0.176573155892445,0.0767681774989531,0.440048751476443
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20691.Liking for milk chocolate,36296,0.22202626800243,0.0636620248288484,0.0972486993378872,0.346803836666973,0.000490143279745603
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20692.Liking for mushrooms,36296,-0.214480171407639,0.0655536375536221,-0.342965301012738,-0.0859950418025393,0.00107326202749323
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20694.Liking for orange juice,36296,0.0587005101074801,0.0650866635159546,-0.068869350383791,0.186270370598751,0.367147649155107
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20695.Liking for oranges,36296,-0.0146563581028837,0.0659191480162948,-0.143857888214821,0.114545172009054,0.824056365610095
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20696.Liking for pasta,36296,-0.135572392506151,0.0647984781782885,-0.262577409735596,-0.00856737527670526,0.0364519453943042
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20697.Liking for pears,36296,0.106656891857387,0.0645879481244493,-0.0199354864665333,0.233249270181308,0.0987092905245377
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20698.Liking for pizza,36296,0.0497602994450332,0.0634993668968343,-0.0746984596727621,0.174219058562828,0.433278705331378
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20699.Liking for plain yogurt,36296,-0.206080650719342,0.0634210266891685,-0.330385863030112,-0.0817754384085716,0.00116143664197284
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20700.Liking for plums,36296,0.00260789934862454,0.0651418214806837,-0.125070070753515,0.130285869450765,0.968066916805521
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20701.Liking for pollock,36296,-0.198122432308218,0.0625075613832545,-0.320637252619397,-0.0756076119970397,0.00153260663334656
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20702.Liking for pork chop,36296,-0.0551569740242509,0.0640685456284725,-0.180731323456057,0.0704173754075552,0.389316851314816
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20703.Liking for porridge,36296,0.123342852139217,0.0642142923877569,-0.00251716094078622,0.249202865219221,0.0547937969596374
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20704.Liking for potato crisps,36296,0.119874038265254,0.0640398784542023,-0.00564412350498285,0.24539220003549,0.0612631590621839
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20705.Liking for potatoes,36296,0.175258420580614,0.0651121871063665,0.0476385338521353,0.302878307309092,0.00712560390336684
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20706.Liking for prawns,36296,-0.336773340595016,0.0642440189519387,-0.462691617740816,-0.210855063449217,1.62986591609629e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20707.Liking for raw carrots,36296,-0.000847790182643284,0.0642301291068749,-0.126738843232118,0.125043262866832,0.989469162449513
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20708.Liking for red meat,36296,-0.0625396394266556,0.0642995791411035,-0.188566814543218,0.0634875356899073,0.330768296669124
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20709.Liking for red wine,36296,-0.66604652759977,0.064112032563885,-0.791706111424985,-0.540386943774556,4.08702308029066e-25
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36296,0.236604335703173,0.0645694818676579,0.110048151242564,0.363160520163783,0.000249649579255568
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20711.Liking for roast chicken,36296,-0.0596148530423589,0.0661256743485943,-0.189221174765604,0.0699914686808859,0.367330223933219
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20712.Liking for salad dressing,36296,-0.145388781496979,0.0638417982785172,-0.270518706122873,-0.0202588568710856,0.0227939286510684
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20713.Liking for salad leaves,36296,-0.189694256687339,0.0639149782497856,-0.314967614056919,-0.064420899317759,0.00300750946848973
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20714.Liking for salami,36296,-0.242301910876745,0.0634650459270727,-0.366693400893807,-0.117910420859682,0.000135661296337252
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20715.Liking for salmon,36296,-0.297439442323121,0.0658004487075464,-0.426408321789912,-0.16847056285633,6.26689470304994e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20716.Liking for salty foods,36296,0.0371236568187843,0.063456606809816,-0.087251292528455,0.161498606166024,0.558548550575703
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20717.Liking for salty pretzels,36296,-0.0493184201871729,0.0633465210127362,-0.173477601372136,0.0748407609977901,0.436268934190773
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20718.Liking for sardines,36296,-0.297922726573553,0.0641063784640783,-0.423571228363146,-0.17227422478396,3.41880412316484e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20719.Liking for sausages (meat),36296,0.0339489911532749,0.064623717898365,-0.0927134959275205,0.16061147823407,0.599366662160932
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20720.Liking for savoury biscuits,36296,0.0516816703202874,0.0638144554620347,-0.0733946623853006,0.176758003025875,0.418037647153692
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36296,-0.497778094328622,0.0639972299063077,-0.623212664944985,-0.372343523712259,8.31874018951368e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20722.Liking for skimmed milk,36296,-0.113077523188657,0.0631844183256031,-0.236918983106839,0.0107639367295255,0.0735507449694275
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20723.Liking for smoked fish,36296,-0.324141802750231,0.0647494950196504,-0.451050812988746,-0.197232792511716,5.6781459575433e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20724.Liking for soft cheese,36296,-0.172580524816983,0.0630247415326565,-0.296109018220989,-0.049052031412976,0.00619002949698463
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20725.Liking for soy sauce,36296,-0.241424611904904,0.0647428257004674,-0.36832055027782,-0.114528673531988,0.000193639790338069
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20726.Liking for soya milk,36296,-0.10446542794608,0.0640910350406642,-0.230083856625782,0.0211530007336214,0.103152227142776
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20727.Liking for spicy foods,36296,-0.214931455400717,0.0644702723366028,-0.341293189180459,-0.088569721620976,0.000860711151451522
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20728.Liking for spinach,36296,-0.376340532336908,0.0644985701494529,-0.502757729829836,-0.24992333484398,5.60177976836787e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20729.Liking for spirits,36296,-0.361926726441188,0.0633545218482438,-0.486101589263746,-0.23775186361863,1.15332162525238e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20730.Liking for strawberries,36296,0.00476015730954433,0.0669367469031972,-0.126435866620722,0.135956181239811,0.943308668008834
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36296,0.0978007909591436,0.063909315043241,-0.0274614665256089,0.223063048443896,0.125982219242328
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20732.Liking for sweet foods,36296,0.430696330806545,0.0639378451014639,0.305378154407676,0.556014507205415,1.7433747728316e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20733.Liking for taking the stairs,36296,-0.329721178168568,0.0648387110094145,-0.456805051747021,-0.202637304590116,3.75813720612924e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20734.Liking for tea with sugar,36296,0.256886724461298,0.0693220709855456,0.121015465329628,0.392757983592967,0.000212288958836902
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20735.Liking for tea without sugar,36296,-0.234598940151103,0.0654682204214089,-0.362916652177064,-0.106281228125141,0.000341247765612642
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20736.Liking for tomato ketchup,36296,0.120174593578356,0.0633560583104268,-0.00400328071008069,0.244352467866792,0.0578900756203417
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20737.Liking for tinned tuna,36296,-0.1471305519967,0.0638635663523135,-0.272303142047235,-0.0219579619461655,0.0212589517640552
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20738.Liking for turnip (white),36296,-0.146335440126144,0.0636823068672971,-0.271152761586046,-0.0215181186662413,0.02159432443313
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20739.Liking for vegetables,36296,-0.0932564017255486,0.0672906718818923,-0.225146118614057,0.0386333151629602,0.165825541953014
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20740.Liking for vinegar,36296,-0.102019154304027,0.0637877886781093,-0.227043220113121,0.0230049115050671,0.109783414651845
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20741.Liking for watching television,36296,0.282647225420175,0.0651625645439792,0.154928598913975,0.410365851926374,1.45906598940959e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20742.Liking for whisky,36296,-0.317106147460932,0.063914316225763,-0.442378207263427,-0.191834087658436,7.1479668989871e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20743.Liking for white bread,36296,0.165810340991237,0.0626912377751362,0.0429355149519696,0.288685167030503,0.00818878269659143
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20744.Liking for white rice,36296,0.0372578973295466,0.0645645326313596,-0.0892885866279182,0.163804381287011,0.563912808699127
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20745.Liking for white wine,36296,-0.355137726607088,0.0638807629890193,-0.480344022065566,-0.22993143114861,2.79800549248281e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36296,-0.151983475800748,0.0644723049811964,-0.278349193563893,-0.0256177580376035,0.0184310556536853
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20747.Liking for whole milk,36296,0.183898544674542,0.0634611381932091,0.0595147138158526,0.308282375533232,0.0037683576173363
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20748.Liking for wholemeal bread,36296,-0.196293708443679,0.0661680554091715,-0.325983097045655,-0.0666043198417029,0.00302045715270306
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20749.Liking for working up a sweat,36296,-0.268082886860885,0.0641218807938902,-0.39376177321691,-0.14240400050486,2.93665691617096e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X21001.Body mass index (BMI),51299,-0.177819650998355,0.0121787841651826,-0.201690067962113,-0.153949234034597,4.58779128634195e-48
EPHA2,Ephrin type-A receptor 2,Physical measures,X21002.Weight,51330,-0.000750804785322401,0.00593164089650205,-0.0123768209424664,0.0108752113718216,0.899276925155468
EPHA2,Ephrin type-A receptor 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36258,-0.00525532343157156,0.00446230470438378,-0.0140014406521638,0.00349079378902065,0.238946820928696
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36059,0.184898037686634,0.0689176144637235,0.0498195133377363,0.319976562035532,0.0073151140640552
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36061,-0.0608015625316845,0.0707812091845953,-0.199532732533491,0.0779296074701221,0.390364196656912
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36062,0.0172952095276355,0.068421954225067,-0.116811820753496,0.151402239808767,0.800450746604876
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21040.Satisfaction with bowel habits,36035,0.113399827449177,0.0634028622389851,-0.0108697825392342,0.237669437437587,0.0737264443651831
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36034,0.130402423761714,0.0689220750675068,-0.00468484337059979,0.265489690894027,0.0585262611893307
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21042.Greatest number of times bowels opened per day,36034,-0.0448290685550875,0.0684675670325271,-0.179025499938841,0.0893673628286657,0.512649654364202
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21043.Least number of times bowels opened per week,36000,-0.0573429994173504,0.0686514985349729,-0.191899936545897,0.0772139377111964,0.403588884506087
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21044.Average number of times bowels opened per day,36010,0.0276561663408636,0.0755327837682127,-0.120388089844833,0.175700422526561,0.714265218321289
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36068,-0.116260441147228,0.0688931100722111,-0.251290936888762,0.0187700545943055,0.0915397619836322
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36064,-0.0891114418242001,0.068912490702216,-0.224179923600543,0.0459570399521433,0.196012988270606
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36066,0.00920917389191736,0.0802446078248536,-0.148070257444796,0.16648860522863,0.908635451408189
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36066,-0.0791699152509613,0.0993028338212804,-0.273803469540671,0.115463639038748,0.425326935183505
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36066,-0.281149663943544,0.0825910956971495,-0.443028211509958,-0.119271116377131,0.000667278890111433
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36064,-0.641074998598021,0.176872925326683,-0.987745932238319,-0.294404064957722,0.000291453755125337
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36068,0.0221030563309293,0.0863189468680483,-0.147082079530445,0.191288192192304,0.797909532795585
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36065,-0.336557188977602,0.0774108030861253,-0.488282363026407,-0.184832014928796,1.39413433515194e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35929,0.233626558718348,0.0779070227074382,0.0809287942117697,0.386324323224927,0.00271967210707819
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36062,-0.0208396475163655,0.0705690914620939,-0.15915506678207,0.117475771749339,0.767766495551482
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36067,-0.241839752042735,0.116724574101715,-0.470619917282096,-0.0130595868033733,0.0383105358499354
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36068,-0.313856335388822,0.0692872361701211,-0.449659318282259,-0.178053352495384,5.99609555607258e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36067,-0.0120926756399408,0.0689999547454701,-0.147332586941062,0.123147235661181,0.860883013220396
EPHA2,Ephrin type-A receptor 2,Working and living environment,X21100.Water hardness (USGS classification),51173,0.0538613313683648,0.0360875347946188,-0.0168702368290879,0.124592899565818,0.135577116697962
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2139.Age first had sexual intercourse,48439,0.00187948106644405,0.00240968135170166,-0.00284349438289121,0.00660245651577931,0.435417373869703
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2149.Lifetime number of sexual partners,46825,-0.193446380208891,0.0413568699487703,-0.274505845308481,-0.112386915109301,2.92490802302367e-06
EPHA2,Ephrin type-A receptor 2,Physical activities,X22032.IPAQ activity group,47683,-0.197416621197454,0.0394321984810735,-0.274703730220358,-0.12012951217455,5.59275203156253e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X22033.Summed days activity,48066,-0.0182534792741857,0.00239355817681489,-0.0229448533007429,-0.0135621052476285,2.53085121696053e-14
EPHA2,Ephrin type-A receptor 2,Physical activities,X22034.Summed minutes activity,47683,-0.0131489761426098,0.0024177955061716,-0.0178878553347061,-0.00841009695051344,5.44170554231625e-08
EPHA2,Ephrin type-A receptor 2,Physical activities,X22037.MET minutes per week for walking,46978,-0.0106993179735899,0.00245812618680934,-0.0155172452997362,-0.00588139064744357,1.35239308680531e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X22038.MET minutes per week for moderate activity,47683,-0.011033378351027,0.0024555251461214,-0.015846207637425,-0.00622054906462909,7.05441626593793e-06
EPHA2,Ephrin type-A receptor 2,Physical activities,X22039.MET minutes per week for vigorous activity,47683,-0.273306998773444,0.0398166019462506,-0.351347538588096,-0.195266458958793,6.89447704224397e-12
EPHA2,Ephrin type-A receptor 2,Physical activities,X22040.Summed MET minutes per week for all activity,46978,-0.0123144947987355,0.00243199237235185,-0.0170811998485452,-0.00754778974892592,4.15516799268192e-07
EPHA2,Ephrin type-A receptor 2,Eye measures,X2217.Age started wearing glasses or contact lenses,47752,-0.00487466911602506,0.00253370204786125,-0.00984072512983311,9.138689778299e-05,0.0543779756788437
EPHA2,Ephrin type-A receptor 2,Working and living environment,X22501.Year ended full time education,33970,-0.0358735488599693,0.0106138598663853,-0.0566767141980845,-0.0150703835218541,0.000730349734629771
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X22506.Tobacco smoking,33933,-0.265799078602349,0.150331640249626,-0.560449093491616,0.0288509362869192,0.0771039248886995
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50028,-0.0434730322587749,0.115605037045147,-0.270058904867264,0.183112840349714,0.706885003549673
EPHA2,Ephrin type-A receptor 2,Physical measures,X23098.Weight,50903,0.00213125930185752,0.00594507533836108,-0.0095210883613302,0.0137836069650452,0.719978879822113
EPHA2,Ephrin type-A receptor 2,Physical measures,X23099.Body fat percentage,50873,-0.0469742170750042,0.00526424928527327,-0.0572921456741398,-0.0366562884758685,4.86975037157077e-19
EPHA2,Ephrin type-A receptor 2,Physical measures,X23100.Whole body fat mass,50829,-0.035158709127848,0.00525458756789307,-0.0454577007609184,-0.0248597174947775,2.26845248412535e-11
EPHA2,Ephrin type-A receptor 2,Physical measures,X23101.Whole body fat-free mass,50897,0.0304777392431801,0.00511898997331847,0.0204445188954759,0.0405109595908843,2.65814774778825e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23102.Whole body water mass,50903,0.0306716922993109,0.00510566770617615,0.0206645835952056,0.0406788010034161,1.91466501078445e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23104.Body mass index (BMI),50903,-0.160396146631445,0.0119680052774526,-0.183853436975252,-0.136938856287638,8.45824591381624e-41
EPHA2,Ephrin type-A receptor 2,Physical measures,X23105.Basal metabolic rate,50903,0.0285243684239925,0.00532180847877225,0.0180936238055989,0.0389551130423861,8.40940258883589e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23106.Impedance of whole body,50903,-0.0168846342758301,0.00419115094567127,-0.0250992901293458,-0.00866997842231442,5.62865407328937e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X23107.Impedance of leg (right),50903,-0.0380634246468941,0.00337633288250186,-0.0446810370965978,-0.0314458121971905,2.12799136070876e-29
EPHA2,Ephrin type-A receptor 2,Physical measures,X23108.Impedance of leg (left),50903,-0.036474505182748,0.00337165951445279,-0.0430829578310755,-0.0298660525344205,3.30620227133918e-27
EPHA2,Ephrin type-A receptor 2,Physical measures,X23109.Impedance of arm (right),50903,0.0205077929665727,0.00415138572535163,0.0123710769448835,0.0286445089882619,7.86928936116662e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23110.Impedance of arm (left),50903,0.0160568850420071,0.00414354100068979,0.00793554468065513,0.0241782254033591,0.000106859339279195
EPHA2,Ephrin type-A receptor 2,Physical measures,X23111.Leg fat percentage (right),50903,-0.0949003362460239,0.00534404145117219,-0.105374657490321,-0.0844260150017264,4.52859597144502e-70
EPHA2,Ephrin type-A receptor 2,Physical measures,X23112.Leg fat mass (right),50903,-0.0776204270758569,0.00577914704817472,-0.0889475552902794,-0.0662932988614345,5.73436838546713e-41
EPHA2,Ephrin type-A receptor 2,Physical measures,X23113.Leg fat-free mass (right),50902,0.0616462617974198,0.00562181783364862,0.0506274988434685,0.0726650247513712,6.5951550243354e-28
EPHA2,Ephrin type-A receptor 2,Physical measures,X23114.Leg predicted mass (right),50902,0.0628788870603151,0.00566232906990564,0.0517807220833,0.0739770520373301,1.41318104525029e-28
EPHA2,Ephrin type-A receptor 2,Physical measures,X23115.Leg fat percentage (left),50902,-0.102387869705453,0.00559156489367374,-0.113347336897053,-0.0914284025138523,2.36673465018682e-74
EPHA2,Ephrin type-A receptor 2,Physical measures,X23116.Leg fat mass (left),50902,-0.080095067455459,0.00612249191104517,-0.0920951516011075,-0.0680949833098105,5.7995825777049e-39
EPHA2,Ephrin type-A receptor 2,Physical measures,X23117.Leg fat-free mass (left),50901,0.0597920733615959,0.00612423349683531,0.0477885757077987,0.0717955710153931,1.79670031168141e-22
EPHA2,Ephrin type-A receptor 2,Physical measures,X23118.Leg predicted mass (left),50901,0.0606321675992971,0.00617151557008934,0.048535997081922,0.0727283381166722,9.81966650540975e-23
EPHA2,Ephrin type-A receptor 2,Physical measures,X23119.Arm fat percentage (right),50901,-0.017022612087728,0.00595128127311422,-0.0286871233830318,-0.00535810079242408,0.00423597037080632
EPHA2,Ephrin type-A receptor 2,Physical measures,X23120.Arm fat mass (right),50900,-0.00682617975370619,0.00650205831935214,-0.0195702140596364,0.005917854552224,0.293798896480733
EPHA2,Ephrin type-A receptor 2,Physical measures,X23121.Arm fat-free mass (right),50899,0.00787916190774943,0.00562600670751396,-0.00314781123897794,0.0189061350544768,0.161380774800289
EPHA2,Ephrin type-A receptor 2,Physical measures,X23122.Arm predicted mass (right),50899,0.00756143443908417,0.00565055111304301,-0.00351364574248013,0.0186365146206485,0.180852568365205
EPHA2,Ephrin type-A receptor 2,Physical measures,X23123.Arm fat percentage (left),50897,-0.0164625989858124,0.00559312303804946,-0.0274251201403893,-0.00550007783123544,0.00325000636947269
EPHA2,Ephrin type-A receptor 2,Physical measures,X23124.Arm fat mass (left),50897,-0.0129095909134967,0.00624613956024314,-0.0251520244515733,-0.000667157375420176,0.0387634682209981
EPHA2,Ephrin type-A receptor 2,Physical measures,X23125.Arm fat-free mass (left),50893,0.00677902533864673,0.00512049396672037,-0.0032571428361252,0.0168151935134187,0.185549613801102
EPHA2,Ephrin type-A receptor 2,Physical measures,X23126.Arm predicted mass (left),50892,0.00706233710628904,0.00515038955900415,-0.0030324264293591,0.0171571006419372,0.170318982133693
EPHA2,Ephrin type-A receptor 2,Physical measures,X23127.Trunk fat percentage,50890,-0.0226534107209828,0.00447714066827985,-0.0314286064308113,-0.0138782150111543,4.23042581381189e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23128.Trunk fat mass,50890,-0.0229035705736199,0.00471682302701958,-0.0321485437065783,-0.0136585974406616,1.20762791300397e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X23129.Trunk fat-free mass,50889,0.0152214877313847,0.00444052455964048,0.00651805959448939,0.0239249158682801,0.00060946266394304
EPHA2,Ephrin type-A receptor 2,Physical measures,X23130.Trunk predicted mass,50888,0.0152404815432738,0.00443587127531917,0.00654617384364822,0.0239347892428994,0.000592023925391741
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23400.Total Cholesterol,41614,-0.0505521118903549,0.00323036228600218,-0.0568836219709191,-0.0442206018097906,1.06188162176613e-54
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,41614,-0.039794103646486,0.00316660932881453,-0.0460006579309625,-0.0335875493620095,5.20275787082738e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",41614,-0.0309225428128349,0.00319000587772862,-0.037174954333183,-0.0246701312924868,3.81517010163788e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23403.VLDL Cholesterol,41614,-0.0141828108091117,0.00329730387445981,-0.0206455264030529,-0.00772009521517049,1.710097854465e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,41614,-0.0464574484625103,0.00315588935396274,-0.0526429915962772,-0.0402719053287433,1.16517297481725e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23405.LDL Cholesterol,41614,-0.0458770863228193,0.00314080056185087,-0.052033055424047,-0.0397211172215916,6.08503441222492e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23406.HDL Cholesterol,41614,-0.0625942011219683,0.00356841612531148,-0.0695882967275788,-0.0556001055163578,4.21255895996955e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23407.Total Triglycerides,41614,0.00379983913306604,0.00335066826637598,-0.00276747066903087,0.010367148935163,0.256792738488967
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23408.Triglycerides in VLDL,41614,0.00160205312883624,0.00340226809900498,-0.00506639234521351,0.00827049860288599,0.637735766108128
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23409.Triglycerides in LDL,41614,0.00446602060261178,0.00315612445997782,-0.00171998333894475,0.0106520245441683,0.157082716064744
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23410.Triglycerides in HDL,41614,0.0149548125283473,0.00327764491264698,0.00853062849955917,0.0213789965571353,5.096894902259e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,41614,-0.0453983494866196,0.00324808187592335,-0.0517645899634293,-0.0390321090098098,4.48581638805307e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23412.Phospholipids in VLDL,41614,-0.0050346006955769,0.00333161529697327,-0.0115645666776445,0.00149536528649072,0.130772205931447
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23413.Phospholipids in LDL,41614,-0.0445244477164228,0.00315332064422937,-0.0507049561791123,-0.0383439392537332,6.14855531244871e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23414.Phospholipids in HDL,41614,-0.0463200123151044,0.00343227193837872,-0.0530472653143267,-0.0395927593158821,3.1495434418766e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23415.Total Esterified Cholesterol,41614,-0.0534209838898067,0.00324482079815686,-0.0597808326541941,-0.0470611351254192,2.72917726420914e-60
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,41614,-0.0169149223871734,0.00327905344466852,-0.0233418671387237,-0.0104879776356231,2.52625603735825e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,41614,-0.0443504868448167,0.00314114104694255,-0.0505071232968241,-0.0381938503928093,6.20314351967905e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,41614,-0.0644193383623031,0.003569629525527,-0.071415812232336,-0.0574228644922701,6.31324428999184e-72
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23419.Total Free Cholesterol,41614,-0.0428087097054921,0.00319760297192401,-0.0490760115304631,-0.036541407880521,1.32334137523562e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,41614,-0.0102078198532154,0.00331911231009263,-0.0167132799809969,-0.0037023597254338,0.00210609019864647
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23421.Free Cholesterol in LDL,41614,-0.0484531373887819,0.00315635058078265,-0.0546395845271159,-0.0422666902504479,1.00973303123979e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23422.Free Cholesterol in HDL,41614,-0.0517079082825472,0.00355817900447061,-0.0586819391313096,-0.0447338774337848,1.78410824721134e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,41614,-0.037735506482347,0.00312724190954644,-0.043864900625058,-0.031606112339636,2.38554727033012e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23424.Total Lipids in VLDL,41614,-0.0040812911468204,0.00333494364978922,-0.0106177807004073,0.00245519840676647,0.22105129886747
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23425.Total Lipids in LDL,41614,-0.0435121637536697,0.0031431725652455,-0.0496727819815509,-0.0373515455257886,2.82533751745086e-43
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23426.Total Lipids in HDL,41614,-0.0514250037641309,0.00348370080953127,-0.0582530573508122,-0.0445969501774496,6.43814709642117e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,41614,-0.0645397334370723,0.00328604718929074,-0.0709803859280821,-0.0580990809460624,1.1661198487751e-84
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23428.Concentration of VLDL Particles,41614,-0.00725815867279463,0.00328764487730028,-0.0137019426323032,-0.000814374713286083,0.0272820391583029
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23429.Concentration of LDL Particles,41614,-0.03147484225377,0.00317063657316625,-0.0376892899371759,-0.0252603945703642,3.83980394950778e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23430.Concentration of HDL Particles,41614,-0.0634305618871025,0.00329138343695579,-0.0698816734235359,-0.0569794503506692,1.26807920925165e-81
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,41614,-0.00160233094490818,0.00345836199544053,-0.00838072045597162,0.00517605856615527,0.643142207774397
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,41614,-0.0160365479988891,0.00328483198905924,-0.0224748186974452,-0.00959827730033298,1.0626202870145e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,41614,-0.0136703994650545,0.00361498902648066,-0.0207557779569566,-0.00658502097315238,0.00015652802409447
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23434.Phosphoglycerides,41606,-0.0432316078660142,0.00325732367524655,-0.0496159622694974,-0.0368472534625309,6.10738223698135e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,41606,0.0299649646368256,0.00352930795898854,0.0230475210372081,0.0368824082364431,2.28251160274367e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23436.Total Cholines,41606,-0.047164054043577,0.00330995725943716,-0.0536515702720739,-0.0406765378150802,1.0019275189227e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23437.Phosphatidylcholines,41606,-0.0435032979285597,0.00332598321755951,-0.0500222250349764,-0.0369843708221431,7.54920966093186e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23438.Sphingomyelins,41606,-0.0512192252375038,0.00334093405893027,-0.0577674559930072,-0.0446709944820005,1.3714109200172e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23439.Apolipoprotein B,41614,-0.0298519934546281,0.00318118192311185,-0.0360871100239273,-0.0236168768853289,7.39649176018833e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23440.Apolipoprotein A1,41614,-0.0539595449030736,0.00340491590645959,-0.0606331800797344,-0.0472859097264128,4.88201335387439e-56
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,41614,0.000776866039558935,0.00326360510064346,-0.00561979995770224,0.00717353203682011,0.811854416275161
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23442.Total Fatty Acids,41606,-0.020556029743335,0.00305644037014004,-0.0265466528688095,-0.0145654066178605,1.82330666952913e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23443.Degree of Unsaturation,41606,-0.0557532710181789,0.00328899352287789,-0.0621996983230196,-0.0493068437133383,9.06836079785055e-64
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,41606,-0.0513076192607967,0.00319512051679546,-0.0575700554737158,-0.0450451830478776,1.78822206695732e-57
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,41606,-0.0321417297317678,0.00315956031127453,-0.0383344679418659,-0.0259489915216698,3.22966255788359e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,41606,-0.040484263247571,0.00316482831575874,-0.0466873267464582,-0.0342811997486839,3.04933013259046e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,41606,-0.000405449640620133,0.00312056275471353,-0.00652175263985866,0.00571085335861839,0.89662510566879
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23448.Saturated Fatty Acids,41606,-0.0203007543576014,0.00301586823687116,-0.0262118561018689,-0.014389652613334,1.75191855477763e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23449.Linoleic Acid,41606,-0.0192410914335392,0.00316262171521438,-0.0254398299953594,-0.013042352871719,1.20582921508889e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23450.Docosahexaenoic Acid,41606,-0.0605165869607423,0.00315715139745054,-0.0667046036997454,-0.0543285702217393,8.85131934212914e-81
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,41606,-0.0503658462514213,0.00321242914093477,-0.0566622073676534,-0.0440694851351891,6.75218975717141e-55
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,41606,-0.00352546986417188,0.0031756140013225,-0.00974967330676397,0.00269873357842022,0.266946510029518
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,41606,-0.0228628494936944,0.00324584480382951,-0.0292247053092002,-0.0165009936781885,1.96578393875585e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,41606,0.0446205492735147,0.00339208280462116,0.0379720669764572,0.0512690315705721,2.86209691214887e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,41606,-0.00925723295815912,0.00296213063799846,-0.0150630090086361,-0.00345145690768214,0.00178078775162849
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,41606,0.00427268186046132,0.00326026277216241,-0.002117433172977,0.0106627968938996,0.190038739216719
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,41606,-0.047290746243731,0.00314622659350788,-0.0534573503670065,-0.0411241421204556,1.2249734582908e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,41606,-0.0363573470638473,0.0033665509422759,-0.0429557869107081,-0.0297589072169866,4.50400336144319e-27
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,41606,0.0438531591377043,0.00317796085018938,0.0376243558713331,0.0500819624040755,5.17986715845753e-43
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23460.Alanine,41612,0.0113797884277676,0.00319539965601482,0.00511680510197859,0.0176427717535567,0.000370335590194482
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23461.Glutamine,41577,-0.000813799889585986,0.00314457298877462,-0.00697716294758425,0.00534956316841227,0.795797490315536
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23462.Glycine,41601,0.0493161103074491,0.00377626144590351,0.0419146378734782,0.05671758274142,9.82927408713512e-39
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23463.Histidine,41599,-0.00508274415220522,0.00315350528253135,-0.0112636145059667,0.00109812620155622,0.107034968346893
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),41603,-0.0250267037437953,0.00355157942309835,-0.0319877994130681,-0.0180656080745225,1.92527238956686e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23465.Isoleucine,41612,-0.00735521889687483,0.00342700010350335,-0.0140721390997414,-0.000638298694008265,0.0318710105779392
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23466.Leucine,41612,-0.0247136300772331,0.00352080018647382,-0.0316143984427218,-0.0178128617117444,2.34003026205239e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23467.Valine,41603,-0.0289250888975067,0.0035247723371447,-0.0358336426783103,-0.0220165351167031,2.49602972883925e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23468.Phenylalanine,41607,0.0217914638558792,0.00325125511290273,0.0154190038345898,0.0281639238771685,2.13364907283403e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23469.Tyrosine,41602,-0.0170000713630592,0.00337490402957815,-0.0236148832610323,-0.010385259465086,4.78723449847772e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23470.Glucose,41594,0.00501657077584955,0.00307077887343784,-0.00100215581608862,0.0110352973677877,0.10235707718101
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23471.Lactate,41596,0.0069710786542563,0.00323811225850186,0.000624378627592645,0.0133177786809199,0.0313510337655769
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23472.Pyruvate,41575,0.00783705502394824,0.00310072827221303,0.00175962761041071,0.0139144824374858,0.0114999324626042
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23473.Citrate,41613,0.0392744852531861,0.00321141327592633,0.0329801152323705,0.0455688552740017,3.32536849631761e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23474.3-Hydroxybutyrate,41344,-0.00143736782724557,0.00356137355886661,-0.00841766000262413,0.00554292434813299,0.686514182007981
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23475.Acetate,41603,-0.00983445553909653,0.00307698335635357,-0.0158653429175495,-0.00380356816064354,0.00139614645139265
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23476.Acetoacetate,41613,-0.0164810300860393,0.00322591119734144,-0.0228038160328286,-0.0101582441392501,3.28534491555409e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23477.Acetone,41613,-0.0203156143598804,0.00320102393461336,-0.0265896212717226,-0.0140416074480382,2.27429552919809e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23478.Creatinine,41371,0.140605660309001,0.00364878065755113,0.133454050220201,0.147757270397801,1.98359575816275e-307
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23479.Albumin,41613,-0.0592343802464908,0.00314675548476471,-0.0654020209966296,-0.0530667394963519,5.2067337130278e-78
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23480.Glycoprotein Acetyls,41614,0.0312958211587046,0.00330625684546819,0.024815557741587,0.0377760845758223,3.41358074660399e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,41614,0.0114413295794914,0.00337471893615194,0.00482688046463355,0.0180557786943492,0.000700221053904765
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,41614,0.00982128836729402,0.00335521559545144,0.0032450658002092,0.0163975109343789,0.00342653266865939
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,41614,0.012930524593763,0.00346555384172316,0.00613803906398565,0.0197230101235404,0.000191413028961532
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,41614,0.00836365195411318,0.00341038313399069,0.00167930101149143,0.0150480028967349,0.0142033892613073
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,41614,0.00638046973471581,0.00341112386694057,-0.0003053330444877,0.0130662725139193,0.0614383680668024
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,41614,0.0103159940427171,0.00338705819145687,0.00367735998746168,0.0169546280979726,0.00232596693570168
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,41614,0.0093794807993762,0.00329177907385384,0.00292759381462268,0.0158313677841297,0.00438753218840467
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,41614,0.00369561950430054,0.0035139384364586,-0.00319169983115831,0.0105829388397594,0.292955373575978
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,41614,0.0021447621610919,0.00349076594424998,-0.00469713908963807,0.00898666341182187,0.538955045827552
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,41614,0.00422039218229391,0.00348849039935483,-0.00261704900044156,0.0110578333650294,0.22637580613177
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,41614,-0.00264325998519857,0.00346836883117315,-0.00944126289429795,0.0041547429239008,0.446011364090874
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,41614,-0.00814160265734652,0.00346459087973783,-0.0149322007816327,-0.00135100453306038,0.0187909715197677
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,41614,0.00287524588611231,0.00345938740696442,-0.00390515343153796,0.00965564520376257,0.405908056856726
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,41614,0.00311221003018755,0.00350010252788098,-0.00374799092445917,0.00997241098483427,0.373924494347179
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,41614,-0.000230221690760841,0.00346272499198835,-0.007017162675058,0.00655671929353632,0.94699216452967
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,41614,-0.00331774820261647,0.00345381855832628,-0.010087232576936,0.00345173617170303,0.336769705027633
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,41614,0.00269076060425748,0.00352045761791604,-0.00420933632685796,0.00959085753537293,0.444689676359086
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,41614,-0.0028747922974124,0.00347985793668672,-0.00969531385331836,0.00394572925849357,0.408749202496002
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,41614,-0.00459093735634744,0.00345480339748973,-0.0113623520154273,0.00218047730273243,0.183918672314334
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,41614,-0.0014057251817917,0.00351107261975576,-0.00828742751651299,0.00547597715292959,0.688891210343798
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,41614,-0.006108360098997,0.0034058856560426,-0.0127838959848405,0.000567175786846492,0.0729207146722186
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,41614,-0.021299164818614,0.00325788495709572,-0.0276846193345216,-0.0149137103027064,6.47915539485267e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,41614,-0.0185676589319968,0.00326698760237531,-0.0249709546326524,-0.0121643632313412,1.34861884543889e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,41614,-0.0212337166372048,0.00324942455249274,-0.0276025887600906,-0.014864844514319,6.61518774570925e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,41614,-0.0298939867805354,0.00319060398077774,-0.0361475705828598,-0.023640402978211,8.48268073870271e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,41614,-0.0324857904060758,0.00318154468504689,-0.0387216179887677,-0.0262499628233839,2.1944783454256e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,41614,-0.0243338495441588,0.00323166953265559,-0.0306679218281638,-0.0179997772601538,5.41591519758211e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,41614,-0.00821570655561367,0.00335968813819853,-0.0148006953064828,-0.00163071780474456,0.0144832092681292
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,41614,-0.00124890559956727,0.00336337828938872,-0.00784112704676916,0.00534331584763463,0.710401711130173
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,41614,-0.00564239208566374,0.00336589235533921,-0.0122395411021286,0.000954756930801104,0.0936949298818984
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,41614,-0.0169171263645808,0.00329967280695923,-0.0233844850662209,-0.0104497676629407,2.98762652444621e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,41614,-0.0155845497544187,0.0033302008244738,-0.0221117433703874,-0.00905735613845009,2.90102227041268e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,41614,-0.0101492511568951,0.00339056116780287,-0.0167947510457887,-0.00350375126800149,0.00276420566083674
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,41614,-0.0240638821308933,0.0032360856695436,-0.0304066100431988,-0.0177211542185879,1.10181596983247e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,41614,0.00915392758494744,0.00339698805564058,0.0024958309958919,0.015812024174003,0.00705384940110726
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,41614,-0.00523218578654711,0.00321738272918955,-0.0115382559357586,0.00107388436266441,0.103926173018674
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,41614,-0.00406545404672194,0.00323993630871955,-0.0104157292118123,0.00228482111836838,0.209575927090378
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,41614,0.00267341217067705,0.00322967933608183,-0.00365675932804334,0.00900358366939744,0.407819364935151
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,41614,-0.017587316059652,0.00325900848658247,-0.0239749726933537,-0.0111996594259504,6.91350541463253e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,41614,-0.0221184253302708,0.00328047045907521,-0.0285481474300582,-0.0156887032304834,1.62304447053878e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,41614,-0.00689396195055279,0.003233203534161,-0.0132310408775084,-0.000556883023597222,0.0330058902620895
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,41614,0.017878756114799,0.00329504173374448,0.0114204743166599,0.0243370379129382,5.86764749121088e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23523.Concentration of IDL Particles,41614,-0.0314857967895407,0.00318227843518478,-0.0377230625225029,-0.0252485310565786,5.32284090945202e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23524.Total Lipids in IDL,41614,-0.0409306827728707,0.0032437408824643,-0.0472884149025007,-0.0345729506432407,2.72807858907321e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23525.Phospholipids in IDL,41614,-0.0353603357746086,0.00324666030992218,-0.041723789982056,-0.0289968815671611,1.66665001763504e-27
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23526.Cholesterol in IDL,41614,-0.0463390149880654,0.0032565560187245,-0.0527218647847654,-0.0399561651913654,1.32160044110639e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,41614,-0.0474886887244379,0.00325971153261929,-0.0538777233283717,-0.041099654120504,1.05925057397559e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23528.Free Cholesterol in IDL,41614,-0.0417669128396789,0.00323823792467601,-0.0481138591720439,-0.035419966507314,7.87155626223211e-38
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23529.Triglycerides in IDL,41614,0.0118366996520525,0.00318625734047665,0.00559163526471825,0.0180817640393867,0.000204116067413146
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,41614,-0.030666918733003,0.00315784960074483,-0.0368563039504629,-0.0244775335155432,3.20952175795217e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23531.Total Lipids in Large LDL,41614,-0.0455868507282245,0.00315598959145415,-0.0517725903274747,-0.0394011111289744,6.2557784558956e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23532.Phospholipids in Large LDL,41614,-0.0472333414439504,0.00316481703819036,-0.0534363828388035,-0.0410303000490973,5.90818427328051e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23533.Cholesterol in Large LDL,41614,-0.047581620038115,0.00315596033154517,-0.0537673022879436,-0.0413959377882865,6.19764232014762e-51
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,41614,-0.0467344893059349,0.00315148278156686,-0.052911395557806,-0.0405575830540639,2.39113497228427e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,41614,-0.0489756065467231,0.0031838685903439,-0.0552159889837971,-0.042735224109649,6.27170226974126e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23536.Triglycerides in Large LDL,41614,0.00429414705544986,0.00315128705018246,-0.00188237556290776,0.0104706696738075,0.173011843666885
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,41614,-0.0341198588111568,0.00319011870205852,-0.0403724914671915,-0.0278672261551221,1.37801269215581e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,41614,-0.0408247543826815,0.00316199417190608,-0.0470222629596174,-0.0346272458057456,6.65990153796038e-38
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,41614,-0.0420579987375506,0.00317279606284179,-0.0482766790207205,-0.0358393184543807,7.56689250114423e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,41614,-0.0429090382474729,0.00315626627750487,-0.0490953201513824,-0.0367227563435633,8.28580779359175e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,41614,-0.0400645928886324,0.00317077323263379,-0.0462793084245946,-0.0338498773526702,2.19745211636832e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,41614,-0.0479436254873437,0.00313698391185484,-0.0540921139545792,-0.0417951370201083,2.80619928041178e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,41614,0.00379992065892928,0.00317327514717291,-0.00241969862952963,0.0100195399473882,0.231142907858397
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,41614,-0.0248148400618618,0.00319727548132646,-0.0310815000052617,-0.018548180118462,9.03580104585852e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23545.Total Lipids in Small LDL,41614,-0.0354670242926933,0.00314523706014832,-0.041631688930584,-0.0293023596548026,2.34745288578585e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23546.Phospholipids in Small LDL,41614,-0.0329223778335841,0.00313754920446739,-0.0390719742743402,-0.026772781392828,1.1773162810206e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23547.Cholesterol in Small LDL,41614,-0.0394756683079519,0.00315157234084175,-0.0456527500960017,-0.033298586519902,8.68530445795125e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,41614,-0.0359620632816613,0.00315541990939286,-0.0421466863040713,-0.0297774402592513,6.0068154300533e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,41614,-0.0442244924206751,0.0031466754205882,-0.050391976245028,-0.0380570085963222,1.53279757093003e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23550.Triglycerides in Small LDL,41614,0.006848961424825,0.00321375453798122,0.000550002530381796,0.0131479203192682,0.0330962818341944
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,41614,-0.0083385062002613,0.00368144105664131,-0.0155541306712783,-0.00112288172924434,0.0235283455718158
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,41614,-0.0051178043236375,0.00369229103060889,-0.0123546947436309,0.00211908609635593,0.165746756151067
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,41614,0.000782420630930152,0.00367307911755804,-0.0064168144394836,0.00798165570134391,0.831318666772092
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,41614,-0.0152979513220823,0.00373076593990483,-0.0226102525642958,-0.00798565007986883,4.14789997830537e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,41614,-0.0210571724690213,0.00374841472147062,-0.0284040653231037,-0.0137102796149389,1.9757434952661e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,41614,0.00431039725944765,0.00362984469258867,-0.00280409833802615,0.0114248928569214,0.2350568337877
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,41614,0.0184566823395801,0.00306751312745113,0.0124443566097759,0.0244690080693843,1.82651088065813e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,41614,-0.0354945439675374,0.00370110219739574,-0.0427487042744331,-0.0282403836606418,1.03647238049985e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23559.Total Lipids in Large HDL,41614,-0.0340453655704976,0.00366913508753618,-0.0412368703420686,-0.0268538607989267,1.98054641227156e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23560.Phospholipids in Large HDL,41614,-0.0325669945082507,0.00363512443006379,-0.0396918383911757,-0.0254421506253257,3.71824389577617e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23561.Cholesterol in Large HDL,41614,-0.0385897594627721,0.00372110214176776,-0.0458831196606369,-0.0312963992649073,4.22923915201074e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,41614,-0.0402429223977404,0.00373266225475074,-0.0475589404170519,-0.032926904378429,5.48531950410286e-27
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,41614,-0.0314664334347083,0.00368202702973035,-0.0386832064129798,-0.0242496604564368,1.41572722234013e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23564.Triglycerides in Large HDL,41614,0.0199972007756354,0.00323049783650683,0.0136654250160821,0.0263289765351888,6.1920952119508e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,41614,-0.0521724248570786,0.00337040603011214,-0.0587784206760984,-0.0455664290380588,1.43017369924778e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,41614,-0.0494431419222804,0.0033165374037107,-0.0559435552335534,-0.0429427286110074,7.52805750051886e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,41614,-0.0446935606469443,0.00326441416586761,-0.0510918124120448,-0.0382953088818438,2.25413679706735e-42
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,41614,-0.0591449772811351,0.00340298297800261,-0.0658148239180203,-0.05247513064425,6.60951640283368e-67
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,41614,-0.0596676927855925,0.00339796258608325,-0.0663276994543157,-0.0530076861168694,3.05540693099807e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,41614,-0.0546357497780965,0.00342234438102048,-0.0613435447648967,-0.0479279547912964,7.8251341839831e-57
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,41614,0.010927535452123,0.00331593855513798,0.00442829588405257,0.0174267750201935,0.000985242520069182
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,41614,-0.0632123218041091,0.00313630418253074,-0.0693594780018693,-0.0570651656063488,5.51005800229418e-89
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23573.Total Lipids in Small HDL,41614,-0.0539883190152005,0.00314373170980647,-0.0601500331664212,-0.0478266048639798,2.20618070738739e-65
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23574.Phospholipids in Small HDL,41614,-0.0500336526588378,0.00313234484979916,-0.0561730485644442,-0.0438942567532314,6.81355290316757e-57
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23575.Cholesterol in Small HDL,41614,-0.0654560452031739,0.00311802529809085,-0.071567374787432,-0.0593447156189159,2.98236298815229e-96
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,41614,-0.0676424184744705,0.00313528635886651,-0.0737875797378489,-0.0614972572110922,1.84728911173824e-101
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,41614,-0.0510496084171022,0.00312280558442645,-0.0571703073625781,-0.0449289094716264,1.77624493659307e-59
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23578.Triglycerides in Small HDL,41614,0.0141183767148848,0.0035649896118648,0.00713099707562984,0.0211057563541399,7.52588621383666e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41245,0.0233926547611637,0.00358682598585895,0.0163624758288802,0.0304228336934472,7.20998988341848e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41245,-0.00883597780344229,0.00344271513412876,-0.0155836994663347,-0.00208825614054992,0.0102823215272909
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41245,-0.0117950651334508,0.00348677573659969,-0.0186291455771862,-0.00496098468971538,0.000719684667692178
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41245,-0.00100400267108788,0.00344517052588026,-0.00775653690181318,0.00574853155963743,0.770732441764304
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41245,0.00199937664888617,0.00348862593758699,-0.00483833018878433,0.00883708348655668,0.566578420987107
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41542,0.016663862383594,0.00351676354172897,0.00977100584180524,0.0235567189253828,2.1769411171469e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41542,-0.0143554031761639,0.00354750949136126,-0.0213085217792319,-0.00740228457309581,5.22657143639366e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41542,-0.0183372357224279,0.00352143547706356,-0.0252392492574725,-0.0114352221873833,1.94526577480038e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41542,0.00399951665429159,0.00356325840159193,-0.00298446981282859,0.0109835031214118,0.261699460636868
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41542,0.0083799116488718,0.00354010515145858,0.00144130555201299,0.0153185177457306,0.0179409539694656
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,41614,0.0394558219122683,0.00365032888269557,0.032301177302185,0.0466104665223516,4.07488989003758e-27
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,41614,0.00231829087843978,0.00344088371947601,-0.00442584121173319,0.00906242296861275,0.500483070146279
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,41614,-0.00113502904172959,0.00349528036280824,-0.00798577855283373,0.00571572046937456,0.745389206930664
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,41614,0.0129022778586926,0.00348556085993964,0.00607057857321087,0.0197339771441743,0.000215097740104754
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,41614,-0.0161892232049793,0.00350184401417328,-0.0230528374727589,-0.00932560893719962,3.81763217144137e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,41614,-0.0177649612220236,0.00336958165807159,-0.0243693412718439,-0.0111605811722033,1.36987323166523e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,41614,-0.025483801656583,0.00348195196008985,-0.0323084274983591,-0.0186591758148069,2.64822976749302e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,41614,-0.0263902387788099,0.00350377413367806,-0.0332576360808189,-0.0195228414768009,5.32829332473562e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,41614,-0.0217215784912801,0.00341028646618986,-0.0284057399650123,-0.015037417017548,1.96116642911635e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,41614,0.0238262104716493,0.00345432098816001,0.0170557413348557,0.0305966796084429,5.53682980268362e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,41614,-0.041771831666358,0.0033811241837276,-0.0483988350664641,-0.0351448282662519,7.22997487943923e-35
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,41614,-0.0250235154684716,0.00328114169510121,-0.0314545531908699,-0.0185924777460732,2.57997564209401e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,41614,-0.0117901613977777,0.0032392006095502,-0.0181389945924961,-0.0054413282030593,0.00027386780859807
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,41614,-0.0414977328745698,0.00341035777546905,-0.0481820341144891,-0.0348134316346505,7.01712888026647e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,41614,0.0302782177813156,0.00330969725228159,0.0237912111668437,0.0367652243957876,6.63184255237817e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,41614,0.0532317725403006,0.00318016636333234,0.0469986464681692,0.059464898612432,3.06169973682511e-62
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,41614,-0.039481681104097,0.00337031864607023,-0.0460875056503947,-0.0328758565577994,1.54617326226202e-31
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,41614,-0.0417007085328926,0.00341291564125734,-0.0483900231897569,-0.0350113938760282,3.80869797384321e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,41614,-0.017605543219473,0.0029976936545199,-0.023481022782332,-0.011730063656614,4.38349869571577e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,41614,0.0316594348268793,0.00333587363559975,0.0251211225011038,0.0381977471526548,2.69184213474388e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,41614,0.0485056774616257,0.00311520256152257,0.0423998804410415,0.0546114744822099,3.5486119519708e-54
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,41614,-0.0561087398366865,0.00325789555820653,-0.0624942151307713,-0.0497232645426017,9.64093225367381e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,41614,-0.0570896641026187,0.00320956859048852,-0.0633804185399762,-0.0507989096652612,5.94942051583276e-70
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,41614,-0.0198482277735177,0.00302381252400822,-0.0257749003205738,-0.0139215552264616,5.43789655700946e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,41614,0.0505110395514494,0.00329128557780475,0.0440601198189521,0.0569619592839467,1.07434913837988e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,41614,0.00112467376157113,0.00322062200552315,-0.00518774536925425,0.0074370928923965,0.726937227424754
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,41614,-0.0556235712965947,0.00325011320937443,-0.0619937931869686,-0.0492533494062208,5.94952697171134e-65
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,41614,-0.0420357032525991,0.00311650745129676,-0.0481440578571408,-0.0359273486480575,3.47530812173962e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,41614,-0.0373031096001428,0.00350272876088442,-0.0441684579714763,-0.0304377612288094,2.24543655072204e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,41614,0.0523836689694114,0.00320352194067215,0.0461047659656939,0.0586625719731288,1.65104635718673e-59
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,41614,0.0042900471118024,0.00331011413995238,-0.00219777660250426,0.0107778708261091,0.194983982384827
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,41614,-0.0523753647977869,0.00324023110874401,-0.0587262177709251,-0.0460245118246486,3.32940388616577e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,41614,-0.017911804325593,0.00330721827571121,-0.024393952145987,-0.0114296565051991,6.20395804892197e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,41614,-0.029081754089426,0.00338676672973778,-0.0357198168797121,-0.02244369129914,9.94420382597058e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,41614,0.0513891813589341,0.00319690846450817,0.045123240768498,0.0576551219493701,1.37576104480445e-57
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,41614,0.0222743014137869,0.00327644772515035,0.0158524638724922,0.0286961389550816,1.10471851636597e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,41614,-0.0515030246789395,0.00318159873485891,-0.0577389581992629,-0.045267091158616,2.28320876223715e-58
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,41614,-0.0224385308986525,0.00325059917120417,-0.0288097052742127,-0.0160673565230924,5.33173040936103e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,41614,-0.0313792938249099,0.00321676257011442,-0.0376841484623341,-0.0250744391874856,2.09690839845565e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,41614,0.0394734699995793,0.00327209983500124,0.0330601543229769,0.0458867856761818,2.47470220089964e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,41604,0.0169170949658833,0.00350182173002486,0.0100535243750345,0.023780665556732,1.37438982372765e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,41604,-0.0300391826670725,0.00303573721950461,-0.0359892276173016,-0.0240891377168435,5.2668521876416e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,41604,-0.0501187986288553,0.00280487910471753,-0.0556163616741017,-0.0446212355836089,1.44620566548603e-70
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,41604,0.0171795608385324,0.00362651503582405,0.0100715913683173,0.0242875303087476,2.18972544754084e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,41604,0.0198486102099037,0.00340397280866218,0.0131768235049258,0.0265203969148815,5.64004947857987e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,41614,0.0121904124218386,0.00323304567193968,0.00585364290483683,0.0185271819388404,0.000163598164308121
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,41614,-0.0334295804044801,0.00340191510196425,-0.04009733400433,-0.0267618268046302,1.03648874419591e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,41614,-0.0338780634552048,0.00327538397112087,-0.0402978160386017,-0.0274583108718079,5.61173894491743e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,41614,-0.00992404581370355,0.0032618397517615,-0.0163172517271561,-0.003530839900251,0.00235113719315642
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,41614,0.0437596582380015,0.0032489772262357,0.0373916628745796,0.0501276536014235,4.49989794221947e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,41614,0.0481834809128109,0.00348296955845987,0.0413568605782295,0.0550101012473922,3.21245664434108e-43
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,41614,-0.051146369055195,0.00346675886411187,-0.0579412164288542,-0.0443515216815357,7.25937812630317e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,41614,-0.0413107198873117,0.00330175874355258,-0.0477821670246748,-0.0348392727499486,1.03354317045339e-35
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,41614,-0.0558413539332243,0.00360469675810047,-0.0629065595791012,-0.0487761482873473,1.19603246889839e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,41614,0.0485014852783466,0.00341327564765712,0.0418114650089387,0.0551915055477546,1.74606609654514e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,41614,0.0161881437647288,0.00320840366580539,0.00989967257975023,0.0224766149497074,4.58330312275357e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,41614,-0.0393608517305796,0.00315918461881545,-0.0455528535834579,-0.0331688498777013,1.9846827940663e-35
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,41614,-0.0382830601366968,0.00311288971202507,-0.0443843239722659,-0.0321817963011276,1.43998083800865e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,41614,-0.00428689470505676,0.00338995224508894,-0.0109312011054311,0.00235741169531757,0.206041514948245
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,41614,0.050216770104028,0.00355132447474164,0.0432561741335344,0.0571773660745216,4.62026179178674e-45
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51092,-0.00147600722849278,0.00265939756678771,-0.00668842645939669,0.00373641200241113,0.57888948573171
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51092,0.000822634049153999,0.00258316524699685,-0.00424036983495983,0.00588563793326783,0.750139210478297
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49598,-0.000179349877297771,0.00247308680366876,-0.00502660001248854,0.004667900257893,0.942188258365301
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49598,-0.00129295569504197,0.00269617788918658,-0.00657746435784766,0.00399155296776372,0.631551454803553
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49598,-0.00238957271807181,0.00267009625837,-0.007622961384477,0.00284381594833339,0.370830066961455
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49598,-0.00264589245058065,0.00245501818037226,-0.00745772808411027,0.00216594318294897,0.281158336318356
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24009.Traffic intensity on the nearest road,51092,-0.0957856044667403,0.0782575700144075,-0.249170441694979,0.0575992327614984,0.220973057089207
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24010.Inverse distance to the nearest road,51092,-5.49101330386612e-05,0.00232611618995072,-0.00461409786534208,0.00450427759926476,0.981167152420681
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24011.Traffic intensity on the nearest major road,51092,0.0018211635594111,0.00231454830096413,-0.0027153511104786,0.00635767822930079,0.431387777368097
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24012.Inverse distance to the nearest major road,51092,-0.00578704223390194,0.00234932964065203,-0.0103917283295799,-0.00118235613822397,0.0137749041529636
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24013.Total traffic load on major roads,51092,-0.0174182469932965,0.0540491902005734,-0.12335465978642,0.0885181657998273,0.747253753884785
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24015.Sum of road length of major roads within 100m,51092,-0.0304694571597799,0.0526173834430313,-0.133599528708121,0.0726606143885613,0.562543779424257
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51092,-0.00329600048490868,0.00266816792180537,-0.0085256096116472,0.00193360864182984,0.216730012698356
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51092,-0.00416501427354816,0.00266765333141059,-0.00939361480311292,0.0010635862560166,0.118466422652206
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51092,-0.00229303365020115,0.00263675921475012,-0.00746108171111138,0.00287501441070908,0.384505960532984
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51055,0.000334768947750269,0.00257907948640756,-0.00472022684560854,0.00538976474110908,0.896724466417764
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24020.Average daytime sound level of noise pollution,51092,-0.00118882954301572,0.00232133690930136,-0.00573864988524639,0.00336099079921496,0.608564071852728
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24021.Average evening sound level of noise pollution,51092,-0.00114069032452122,0.00232138599664127,-0.00569060687793811,0.00340922622889567,0.623160164364228
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24022.Average night-time sound level of noise pollution,51092,-0.00119995250424209,0.00232137541117947,-0.00574984831015386,0.00334994330166968,0.605220959590099
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51092,-0.00113956436125133,0.00232119795236204,-0.00568911234788092,0.00340998362537826,0.623475064586145
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51092,-0.00113324053825889,0.00232123503891732,-0.00568286121453685,0.00341638013801906,0.625408796577314
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2405.Number of children fathered,51103,-0.155920637768215,0.0409842127862201,-0.236249694829206,-0.0755915807072233,0.000142520012941326
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48675,0.0039271296260206,0.00274777335112663,-0.00145850614218759,0.00931276539422879,0.152961067906729
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48675,0.00233171925849915,0.00247239402887868,-0.00251417303810306,0.00717761155510136,0.345640184604807
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24502.Water percentage, buffer 1000m",48675,-0.000845364964582039,0.00249424392128337,-0.00573408305029745,0.00404335312113337,0.734668765690933
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48675,0.00158159345148632,0.00257899803541565,-0.00347324269792836,0.006636429600901,0.539712124430537
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48675,0.00357724236273694,0.00249408371881194,-0.00131116172613447,0.00846564645160835,0.151504753125359
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24505.Water percentage, buffer 300m",48675,-0.00164197741422936,0.00251480590023639,-0.00657099697869268,0.00328704215023396,0.513812679156698
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51174,0.0038957033675242,0.00263271849344431,-0.00126442487962664,0.00905583161467504,0.138960200609066
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51174,0.000312205506662229,0.00246521026714123,-0.00451960661693457,0.00514401763025903,0.899222843116022
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24508.Distance (Euclidean) to coast,51174,0.00663305433296871,0.00232939950392546,0.00206743130527481,0.0111986773606626,0.00440985600815406
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2867.Age started smoking in former smokers,35233,-0.0144750270769751,0.00444872990399264,-0.0231945376888007,-0.0057555164651495,0.00114465468781822
EPHA2,Ephrin type-A receptor 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36683,0.0809859810874168,0.0903812231638154,-0.0961612163136613,0.258133178488495,0.370253423360974
EPHA2,Ephrin type-A receptor 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36682,0.0700008781086437,0.10286954255045,-0.131623425290239,0.271625181507526,0.496218775882418
EPHA2,Ephrin type-A receptor 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36683,0.107489292634128,0.0957226915847846,-0.0801271828720494,0.295105768140306,0.261503200818492
EPHA2,Ephrin type-A receptor 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36672,0.167084102096501,0.0959966223944718,-0.0210692777966638,0.355237481989666,0.0818057553862301
EPHA2,Ephrin type-A receptor 2,Mental health,X28739.Difficulty with standing for long periods,36689,0.463230749385732,0.081507829926642,0.303475402729514,0.622986096041951,1.36734899471634e-08
EPHA2,Ephrin type-A receptor 2,Mental health,X28740.Difficulty with taking care of household responsibilities,36707,0.285330688020024,0.0951409022670067,0.0988545195766909,0.471806856463357,0.00271660745527066
EPHA2,Ephrin type-A receptor 2,Mental health,X28741.Difficulty learning a new task,36662,0.173686564921986,0.112281327177003,-0.0463848363449399,0.393757966188911,0.121929676876144
EPHA2,Ephrin type-A receptor 2,Mental health,X28742.Difficulty with joining in community activities,36251,0.115659584020972,0.104210258314528,-0.0885925222755033,0.319911690317448,0.267091000655979
EPHA2,Ephrin type-A receptor 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36655,0.325438311190014,0.0894672247569583,0.150082550666375,0.500794071713652,0.000277002724530613
EPHA2,Ephrin type-A receptor 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36712,0.160551058605603,0.120761411188299,-0.0761413073234622,0.397243424534668,0.183723843695405
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34661,-0.00301621935555088,0.0745741646169726,-0.149181582004817,0.143149143293715,0.967738968024009
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2897.Age stopped smoking,35227,0.0233633843624781,0.00468108391104811,0.0141884598968238,0.0325383088281324,6.15938578331194e-07
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35792,-0.00343595310925837,0.00811154679421666,-0.019334584825923,0.0124626786074063,0.671879044979166
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35792,0.00715311024309377,0.00918583284535282,-0.0108511221337978,0.0251573426199853,0.436175519751624
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35792,0.000767131813986349,0.0303389719664876,-0.0586972532403293,0.060231516868302,0.97982805310514
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35792,-0.0124476954054904,0.0300465667958529,-0.0713389663253622,0.0464435755143814,0.678681323544821
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35792,-0.0134887358422436,0.0367724962744866,-0.0855628285402373,0.0585853568557501,0.713767147662309
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35792,-0.0171269909778413,0.0344662251333307,-0.0846807922391694,0.0504268102834868,0.619259952706192
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35792,-0.00566336984437733,0.0137645766087406,-0.0326419399975089,0.0213152003087542,0.68075833007219
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35792,0.0025912828306442,0.02588073335237,-0.048134954540001,0.0533175202012894,0.920248663818234
EPHA2,Ephrin type-A receptor 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35745,0.221881609851066,0.0982504869221431,0.0293106554836654,0.414452564218466,0.0239553973005305
EPHA2,Ephrin type-A receptor 2,Mental health,X29003.Recent feelings of depression,35746,0.369385066926551,0.0963512829474529,0.180536552349543,0.558233581503558,0.00012729757171075
EPHA2,Ephrin type-A receptor 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35749,0.0498152909931008,0.0776660488901618,-0.102410164831616,0.202040746817818,0.521280998783801
EPHA2,Ephrin type-A receptor 2,Mental health,X29005.Recent feelings of tiredness or low energy,35751,0.174103524555634,0.076060645647349,0.0250246590868303,0.323182390024438,0.0221078370885134
EPHA2,Ephrin type-A receptor 2,Mental health,X29006.Recent poor appetite or overeating,35758,0.269911344855878,0.119421291500917,0.0358456135140807,0.503977076197675,0.023841189635143
EPHA2,Ephrin type-A receptor 2,Mental health,X29007.Recent feelings of inadequacy,35733,0.161826382171039,0.10729114122533,-0.0484642546306087,0.372117018972686,0.131524081314792
EPHA2,Ephrin type-A receptor 2,Mental health,X29008.Recent trouble concentrating on things,35753,0.0569310013374655,0.102891819724265,-0.144736965322093,0.258598967997025,0.580068927555966
EPHA2,Ephrin type-A receptor 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35751,0.294465376274498,0.170436912835193,-0.0395909728824809,0.628521725431477,0.0840836085890254
EPHA2,Ephrin type-A receptor 2,Mental health,X29010.Recent thoughts of suicide or self-harm,35731,0.521528720691193,0.18038356058111,0.167976941952217,0.87508049943017,0.00384907940747407
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#0.Substances taken for depression_None of options listed,35699,-0.0290916226872969,0.017991224070473,-0.064354421865424,0.00617117649083018,0.105924951003037
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35699,0.00672752306943405,0.0330859655163328,-0.0581209693425783,0.0715760154814464,0.838879305683557
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35699,-0.0161717693365001,0.0199034837967378,-0.0551825975781062,0.0228390589051059,0.416526592831079
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35699,-0.0759526494743434,0.0597065843153454,-0.19297755473242,0.0410722557837337,0.203379832793282
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35699,0.0336344832449294,0.0394257896067341,-0.0436400643842694,0.110909030874128,0.393627821956558
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35699,-0.0326263989851984,0.044952958326483,-0.120734197305105,0.0554813993347083,0.467991561974635
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35699,0.028134297388068,0.0472717220104549,-0.0645182777524235,0.12078687252856,0.551754656958179
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35699,-0.0371665792531692,0.0551631340717442,-0.145286322033788,0.0709531635274493,0.50048738895945
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35699,-0.00855676103179999,0.0388684481226703,-0.0847389193522338,0.0676253972886338,0.825763226792701
EPHA2,Ephrin type-A receptor 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35699,-0.0320414870156698,0.0169368119725568,-0.0652376384818811,0.00115466445054151,0.0585549410185472
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35699,-0.0365195177665978,0.0274175775061839,-0.0902579696787182,0.0172189341455225,0.182911284294043
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35699,-0.0270531232083645,0.0442403718898381,-0.113764252112447,0.0596580056957182,0.54088616801482
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35699,0.0146897105481444,0.0527023473995735,-0.0886068903550197,0.117986311451309,0.780460371172487
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35699,-0.00437654894321328,0.0326640072703424,-0.0683980031930845,0.0596449053066579,0.893416734621602
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35699,0.0598610028324043,0.0495193981272282,-0.0371970174969629,0.156919023161771,0.22676478655356
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35699,-0.0126071581947607,0.0491035075309702,-0.108850032955462,0.0836357165659409,0.797381842173853
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35699,0.0589712895573465,0.0269944154881031,0.00606223520066437,0.111880343914029,0.0289527152114918
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35699,0.0298023116534624,0.0264241066920973,-0.0219889374630483,0.0815935607699731,0.259423261029194
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35699,0.0269950310230953,0.039398105679119,-0.0502252561079779,0.104215318154168,0.493248919345753
EPHA2,Ephrin type-A receptor 2,Mental health,X29058.Recent feelings or nervousness or anxiety,35639,0.0953766243130941,0.0949917490336254,-0.0908072037928118,0.281560452419,0.315388231996675
EPHA2,Ephrin type-A receptor 2,Mental health,X29059.Recent inability to stop or control worrying,35644,0.137035184214431,0.0997150705952305,-0.0584063541522208,0.332476722581083,0.169402375684146
EPHA2,Ephrin type-A receptor 2,Mental health,X29060.Recent worrying too much about different things,35643,0.118268239617748,0.0894776040576276,-0.0571078643352025,0.293644343570698,0.186289826458861
EPHA2,Ephrin type-A receptor 2,Mental health,X29061.Recent trouble relaxing,35641,0.0687575230259491,0.0962264903095595,-0.119846397980787,0.257361444032686,0.474918011062007
EPHA2,Ephrin type-A receptor 2,Mental health,X29062.Recent restlessness,35648,0.23256564893975,0.130081864102458,-0.022394804701068,0.487526102580568,0.0738446746014338
EPHA2,Ephrin type-A receptor 2,Mental health,X29063.Recent easy annoyance or irritability,35635,0.0933630946882696,0.0919421589618627,-0.0868435368769814,0.27356972625352,0.309924075433863
EPHA2,Ephrin type-A receptor 2,Mental health,X29064.Recent feelings of foreboding,35641,0.1140343841041,0.114116476459836,-0.109633909757178,0.337702677965378,0.317693117446822
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35699,-0.0349578394527655,0.0211900540051067,-0.0764903453027747,0.00657466639724371,0.0990426867456776
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35699,-0.0398160531203343,0.0317241881928763,-0.101995461978372,0.0223633557377033,0.209494935427779
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35699,-0.00830322488941033,0.0439528404749996,-0.0944507922204096,0.0778443424415889,0.850167083513832
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35699,0.0174154039843859,0.0439060087792624,-0.0686403732229683,0.10347118119174,0.691636060861523
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35699,-0.016777453053045,0.0279866761556654,-0.0716313383181493,0.0380764322120592,0.548871964378994
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35699,0.0348374524719818,0.0348369601083285,-0.0334429893403422,0.103117894284306,0.317337752653396
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35699,-0.0549346807719701,0.0326545712270317,-0.118937640376952,0.00906827883301206,0.0925552794004146
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35699,-0.0160003514484784,0.0330841827044529,-0.080845349549206,0.0488446466522493,0.628666654168209
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35699,0.00314676825047192,0.041206694763828,-0.077618353486631,0.0839118899875748,0.939130499247827
EPHA2,Ephrin type-A receptor 2,Mental health,X29076.Felt loved as a child,35610,-0.0129155628763727,0.0775760090953376,-0.164964540703234,0.139133414950489,0.867776834333956
EPHA2,Ephrin type-A receptor 2,Mental health,X29077.Physically abused by family as a child,35623,0.127363529372731,0.100081581443573,-0.068796370256672,0.323523429002134,0.203203198424821
EPHA2,Ephrin type-A receptor 2,Mental health,X29078.Felt hated by family member as a child,35615,0.269473244910128,0.11098223292823,0.0519480683707972,0.486998421449459,0.0152041729890866
EPHA2,Ephrin type-A receptor 2,Mental health,X29079.Sexually molested as a child,35601,0.0144174094712968,0.166624161228349,-0.312165946536267,0.34100076547886,0.93105034759102
EPHA2,Ephrin type-A receptor 2,Mental health,X29080.Someone to take to doctor when needed as a child,35610,-0.109769772412825,0.117546294245737,-0.340160509134468,0.120620964308819,0.350417114226444
EPHA2,Ephrin type-A receptor 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35617,0.0819189199134438,0.170392965939885,-0.252051293328732,0.415889133155619,0.630698745870899
EPHA2,Ephrin type-A receptor 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35592,0.357273683839667,0.141369617268686,0.080189233993042,0.634358133686292,0.0115184478008996
EPHA2,Ephrin type-A receptor 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35629,0.122468329529019,0.164734280028813,-0.200410859327453,0.445347518385492,0.457246518310609
EPHA2,Ephrin type-A receptor 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35623,0.250392191449143,0.516731108171794,-0.762400780567574,1.26318516346586,0.627996789326681
EPHA2,Ephrin type-A receptor 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35615,-0.124395845514377,0.324313044258721,-0.76004941226147,0.511257721232715,0.701310881686035
EPHA2,Ephrin type-A receptor 2,Mental health,X29086.Experienced a violent or sexual assault,35635,-0.0974767928536084,0.182451799446441,-0.455082319768632,0.260128734061415,0.593178188869574
EPHA2,Ephrin type-A receptor 2,Mental health,X29087.Experienced a life-threatening injury or illness,35628,0.300819002396341,0.0866607158454177,0.130963999339323,0.47067400545336,0.000521201516368795
EPHA2,Ephrin type-A receptor 2,Mental health,X29088.Experienced a marital separation or divorce,35625,-0.222990820062615,0.0894863030416273,-0.398383974024204,-0.0475976661010255,0.0127291019178463
EPHA2,Ephrin type-A receptor 2,Mental health,X29089.Experienced the death of a spouse or partner,35636,0.0973872416499759,0.130681135442732,-0.158747783817779,0.353522267117731,0.456158792646631
EPHA2,Ephrin type-A receptor 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35628,0.0557392140354952,0.108148657884382,-0.156232155417893,0.267710583488884,0.606293649002906
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29091.Frequency of drinking alcohol,35622,-0.773207654254222,0.0717443000954901,-0.913826482441383,-0.632588826067061,7.14784323289509e-27
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35037,-0.693348951839117,0.0788347499608908,-0.847865061762463,-0.538832841915771,1.81283292081896e-18
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35056,-0.763704708644221,0.0791269138078095,-0.918793459707528,-0.608615957580915,6.79716615369967e-22
EPHA2,Ephrin type-A receptor 2,Mental health,X29104.Ever used cannabis,35617,-0.456659933780406,0.0994713695133181,-0.65162381802651,-0.261696049534303,4.4909806746906e-06
EPHA2,Ephrin type-A receptor 2,Mental health,X29108.Ever thought that life not worth living,35589,0.16945904477633,0.0956433251048838,-0.0180018724292421,0.356919961981902,0.0764744554169249
EPHA2,Ephrin type-A receptor 2,Mental health,X29109.Ever contemplated self-harm,35596,0.272022069744088,0.133188128239089,0.010973338395473,0.533070801092704,0.0411503016846509
EPHA2,Ephrin type-A receptor 2,Mental health,X29111.Ever self-harmed,35609,0.130265774609592,0.240409638082803,-0.340937116032701,0.601468665251886,0.58793960837821
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35611,0.308192906378023,0.144747799558387,0.0244872192435847,0.591898593512461,0.0332748182809676
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36289,0.0299764955302177,0.0424849998031378,-0.0532941040839324,0.113247095144368,0.480471774600696
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36289,0.0131763846892319,0.0334392825164748,-0.0523646090430587,0.0787173784215225,0.693563101398965
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36289,0.0122511223347768,0.0413301729477419,-0.0687560166427973,0.0932582613123508,0.766916759422371
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36289,0.0231552250006274,0.0706689069922369,-0.115355832704157,0.161666282705412,0.743179266258138
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35603,-0.00161522989170915,0.0824500007719925,-0.163217231404814,0.159986771621396,0.984370666726681
EPHA2,Ephrin type-A receptor 2,Health and medical history,X29153.Pain or discomfort today,35614,0.154877359626759,0.075412282961619,0.00706928502198628,0.302685434231533,0.0400376928449822
EPHA2,Ephrin type-A receptor 2,Mental health,X29154.Anxiety or depression today,35614,0.174861293766444,0.0989275690352186,-0.0190367415425849,0.368759329075472,0.0771764927874635
EPHA2,Ephrin type-A receptor 2,Mental health,X29166.Frequency of confiding in someone close,35446,-0.112333225342337,0.0751133939521649,-0.25955547748858,0.0348890268039063,0.134826146352706
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35598,0.0186072964723292,0.00764587160800053,0.00362138812064814,0.0335932048240102,0.0149727261576929
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35598,-0.00221201549880904,0.00789888374072635,-0.0176938276306327,0.0132697966330146,0.779453918827504
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35598,-0.0522619959039257,0.00840059764302287,-0.0687271672842505,-0.0357968245236009,5.21729167304741e-10
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35598,0.0314474766100546,0.0116913097078399,0.00853250958268836,0.0543624436374209,0.00716609460045255
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35598,0.0141853198375768,0.0232893083200331,-0.0314617244696882,0.0598323641448418,0.542483560642562
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35598,0.0101119779578599,0.00855322276165471,-0.00665233865498331,0.0268762945707031,0.237149917145876
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35593,0.00504761970883755,0.0089822868008682,-0.0125576624208641,0.0226529018385392,0.574166302896636
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35593,-0.0133512388217452,0.0140867711081734,-0.040961310193765,0.0142588325502746,0.343271362381493
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35593,-0.0498762979063452,0.0162165759712341,-0.0816607868099641,-0.0180918090027263,0.00210864523645662
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35593,0.0363508680816043,0.0195901999772393,-0.00204592387378474,0.0747476600369933,0.06355778804127
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35593,0.0320186591694549,0.0331919257711337,-0.0330375153419671,0.0970748336808769,0.334752477631099
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35593,0.0085459544392973,0.0131055232102502,-0.0171408710527931,0.0342327799313877,0.51436583562862
EPHA2,Ephrin type-A receptor 2,Mental health,X29171.Frequency of feeling 'in tune' with people,35421,-0.270856586511052,0.0910963744889229,-0.449405480509341,-0.0923076925127636,0.00295649647192747
EPHA2,Ephrin type-A receptor 2,Mental health,X29172.Freuency of feeling that lacks companionship,35551,0.186527742110634,0.0856258427709615,0.0187010902795495,0.354354393941719,0.0294094103598763
EPHA2,Ephrin type-A receptor 2,Mental health,X29173.Frequency of feeling left out,35526,0.245017254762621,0.0885632949016946,0.0714331967552992,0.418601312769942,0.00567983114555251
EPHA2,Ephrin type-A receptor 2,Mental health,X29174.Frequency of feeling isolated from others,35558,0.15018158004792,0.0910647420588861,-0.0283053143874968,0.328668474483337,0.0991571973896951
EPHA2,Ephrin type-A receptor 2,Mental health,X29175.Tendency to bounce back quickly after hard times,35607,-0.116224648562841,0.0739530774293222,-0.261172680324312,0.0287233831986307,0.116088541226396
EPHA2,Ephrin type-A receptor 2,Mental health,X29176.Ability to make it through stressful events,35607,0.155302283957599,0.0719026643112852,0.0143730619074796,0.296231506007718,0.0308145369554543
EPHA2,Ephrin type-A receptor 2,Mental health,X29177.Quick recovery from stressful events,35607,-0.180819136687622,0.0735831842898313,-0.325042177895691,-0.0365960954795527,0.0140209542305532
EPHA2,Ephrin type-A receptor 2,Mental health,X29178.Hard to snap back when something bad happens,35607,0.188058411556076,0.0724895037511701,0.0459789842037828,0.33013783890837,0.00949854103918101
EPHA2,Ephrin type-A receptor 2,Mental health,X29179.Comes through difficult times with little trouble,35607,-0.207586526144517,0.0734352974487647,-0.351519709144096,-0.0636533431449386,0.00471497025239148
EPHA2,Ephrin type-A receptor 2,Mental health,X29180.Tendency to take a long time to get over setbacks,35607,0.169315615954457,0.0727089888884339,0.0268059977331263,0.311825234175787,0.0199045906087699
EPHA2,Ephrin type-A receptor 2,Mental health,X29181.General happiness,35570,0.0914126323764269,0.0744372035738362,-0.0544842866282919,0.237309551381146,0.219469566903181
EPHA2,Ephrin type-A receptor 2,Mental health,X29182.Belief that own life is meaningful,35475,-0.117412940291788,0.0753852011030203,-0.265167934453708,0.0303420538701321,0.119396328903341
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34589,-0.0324532442138172,0.0661626787936484,-0.162132094649368,0.0972256062217337,0.623793288205306
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2946.Father's age,33355,-0.0201391712231486,0.0069494740333675,-0.0337601403285489,-0.00651820211774826,0.00377337184517081
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2966.Age high blood pressure diagnosed,35261,-0.0378221977342328,0.00671056334561279,-0.0509749018916339,-0.0246694935768317,1.80938081593254e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50752,0.0225282682224317,0.00249107161614164,0.0176457678547941,0.0274107685900693,1.6374396365891e-19
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50753,-0.036715617424799,0.00266590945577463,-0.0419407999581173,-0.0314904348914807,5.62818082866579e-43
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30020.Haemoglobin concentration,50753,-0.057176866959675,0.00278963478926533,-0.0626445511466351,-0.051709182772715,1.68001772591439e-92
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30030.Haematocrit percentage,50753,-0.0480959962005424,0.00274557667882813,-0.0534773264910455,-0.0427146659100392,3.03352576589276e-68
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30040.Mean corpuscular volume,50753,-0.00880506396399324,0.00247047528739179,-0.0136471955272811,-0.00396293240070533,0.00036585007532347
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50753,-0.0184836558423835,0.002475370449978,-0.0233353819243404,-0.0136319297604266,8.50573460423776e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50753,-0.0204007069729784,0.00240443431651755,-0.0251133982333528,-0.015688015712604,2.29804505060591e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50753,0.0519256207638848,0.00249593594516787,0.0470335863113558,0.0568176552164139,3.23565564952935e-95
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30080.Platelet count,50753,-0.0121333892027231,0.00246485182807241,-0.016964498785745,-0.00730227961970117,8.60316706536768e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30090.Platelet crit,50753,-0.00762296136913455,0.00250620217096147,-0.012535117624219,-0.00271080511405007,0.00235569304203896
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50753,0.0101215802051103,0.00233166074892262,0.00555152513722194,0.0146916352729986,1.42508590733262e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30110.Platelet distribution width,50753,0.00619438891168697,0.00239332803014625,0.00150346597260032,0.0108853118507736,0.00965445973686339
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30120.Lymphocyte count,50716,-0.0126032642959426,0.00241894525091236,-0.0173443969877308,-0.00786213160415437,1.90296772054366e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30130.Monocyte count,50716,0.0166791419213737,0.00242479393199875,0.0119265458146562,0.0214317380280913,6.20643746858259e-12
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30140.Neutrophill count,50716,0.0236254304241903,0.00246061921124234,0.0188026167701553,0.0284482440782252,8.69606852233994e-22
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30150.Eosinophill count,50716,0.0258526595127274,0.00234057346470233,0.0212651355219108,0.0304401835035439,2.7348158707464e-28
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30160.Basophill count,50716,0.0882771510433533,0.0396169014219211,0.010628024256388,0.165926277830319,0.0258725333331398
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30170.Nucleated red blood cell count,50716,0.239815113268459,0.184607122386555,-0.122014846609188,0.601645073146106,0.193938025798763
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30180.Lymphocyte percentage,50717,-0.0287655462232575,0.00238756950983885,-0.0334451824625417,-0.0240859099839734,2.52572565849315e-33
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30190.Monocyte percentage,50717,0.00164593082442544,0.00240108574118021,-0.00306019722828777,0.00635205887713865,0.493039179159115
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30200.Neutrophill percentage,50717,0.0169574430470649,0.00235882981423131,0.0123341366111715,0.0215807494829582,6.73813819476313e-13
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30210.Eosinophill percentage,50717,0.0186660585422874,0.0023219011609772,0.0141151322667721,0.0232169848178027,9.49836960284029e-16
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30220.Basophill percentage,50717,0.00172937571141068,0.00242101995093159,-0.00301582339241524,0.0064745748152366,0.475038720275705
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50716,0.240921207217852,0.184552192956435,-0.12080109097676,0.602643505412464,0.191757766406909
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30240.Reticulocyte percentage,50376,0.00879829459759423,0.00256433778329479,0.00377219254233643,0.013824396652852,0.00060243176620417
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30250.Reticulocyte count,50376,0.000162382568327267,0.00258740966690935,-0.00490894037881505,0.00523370551546958,0.949959198468189
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30260.Mean reticulocyte volume,50376,0.018217559777718,0.00242696458260469,0.0134607091958129,0.0229744103596232,6.31495515100069e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30270.Mean sphered cell volume,50376,-0.000337298434500354,0.00244330822154204,-0.00512618254872276,0.00445158567972205,0.890202263826585
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30280.Immature reticulocyte fraction,50376,0.0151527463471556,0.00252373866516831,0.0102062185634257,0.0200992741308855,1.95460310639814e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50376,0.0129031205918547,0.0025948158973146,0.00781728143311805,0.0179889597505913,6.65446577838147e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30300.High light scatter reticulocyte count,50376,0.00592589109677759,0.00260558727770163,0.000818940032482405,0.0110328421610728,0.0229575479877711
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30500.Microalbumin in urine,36733,0.0839897251555344,0.00424853278862975,0.0756626008898201,0.0923168494212487,5.32087352372203e-85
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50789,-0.00168089149783463,0.0025988599957249,-0.00677465708945542,0.00341287409378617,0.517780821619484
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30520.Potassium in urine,50745,-0.0271984868362791,0.0024216183482064,-0.0319448587987637,-0.0224521148737946,3.42398022193106e-29
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30530.Sodium in urine,50757,-0.0165188254700702,0.00251116958929974,-0.0214407178650977,-0.0115969330750428,4.86997418482358e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30600.Albumin,48656,-0.074969924195126,0.00252779923364504,-0.0799244106930703,-0.0700154376971817,3.19279034762123e-189
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30610.Alkaline phosphatase,50339,0.0723892625152172,0.0024910459475601,0.0675068124579994,0.077271712572435,3.49836745893784e-182
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30620.Alanine aminotransferase,50328,-0.0127932506704868,0.00273969981628189,-0.0181630623103993,-0.00742343903057433,3.03618634846962e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30630.Apolipoprotein A,48595,-0.0421788175110895,0.00278541788335879,-0.0476382365624727,-0.0367193984597062,1.63438150369925e-51
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30640.Apolipoprotein B,50181,-0.0328432775934113,0.00236682223801254,-0.0374822491799159,-0.0282043060069067,1.35314631672872e-43
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30650.Aspartate aminotransferase,50266,0.0107897563323722,0.0025222277716831,0.00584618989987331,0.0157333227648711,1.89500870045441e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30660.Direct bilirubin,48857,0.0023527544856841,0.00256479884952725,-0.00267425125938931,0.0073797602307575,0.358983204019775
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30670.Urea,50323,0.0767073319370894,0.00243587881558266,0.0719330094585474,0.0814816544156314,7.03718511881861e-213
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30680.Calcium,48646,-0.0297788606025247,0.00255161606561658,-0.0347800280911332,-0.0247776931139162,2.27603709675881e-31
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30690.Cholesterol,50342,-0.0403730909309754,0.00238053575618555,-0.045038941013099,-0.0357072408488517,4.21973604036263e-64
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30700.Creatinine,50330,0.15115476523548,0.00292770896151741,0.145416455670906,0.156893074800054,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30710.C-reactive protein,50265,0.0398804439706657,0.00263980709242899,0.0347064220695049,0.0450544658718265,2.64561546864895e-51
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30720.Cystatin C,50347,0.225620034961466,0.00241438684527237,0.220887836744732,0.2303522331782,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30730.Gamma glutamyltransferase,50325,-0.0102921872851578,0.00288836657509451,-0.015953385772343,-0.00463098879797253,0.000366971981075436
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30740.Glucose,48624,0.00142390019645995,0.00243261556425789,-0.00334402630948551,0.00619182670240541,0.55832765394245
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50237,0.0167956303543468,0.0024384477229349,0.0120162728173944,0.0215749878912992,5.82004886031294e-12
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30760.HDL cholesterol,48634,-0.0534844076193324,0.00286398557142414,-0.0590978193393238,-0.0478709958993411,3.58875872758112e-77
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30770.IGF-1,50239,-0.00279586230158415,0.00254214406558019,-0.00777846467012133,0.00218674006695303,0.271429405981241
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30780.LDL direct,50291,-0.0354023289639588,0.00238038049286743,-0.040067874729979,-0.0307367831979386,8.74300685978315e-50
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30790.Lipoprotein A,45932,-0.00450660867399253,0.00261554934030386,-0.00963308538098809,0.000619868033003044,0.0849051753168761
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30810.Phosphate,48593,0.000206601762280698,0.00249216479252124,-0.00467804123106092,0.00509124475562232,0.933931468877834
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30830.SHBG,48506,0.0481213492093723,0.00330753930896328,0.0416385721638043,0.0546041262549403,1.04187865559703e-47
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30840.Total bilirubin,50250,-0.0163925636248632,0.00261591211924315,-0.0215197513785798,-0.0112653758711467,3.7626226141463e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30850.Testosterone,50119,0.0121439116724642,0.00409356765661259,0.00412051906550352,0.0201673042794249,0.00301459118116867
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30860.Total protein,48622,-0.0372504033332544,0.00252192217026838,-0.0421933707869804,-0.0323074358795283,4.10935278533037e-49
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30870.Triglycerides,50317,0.00868486364384981,0.00250939600976436,0.00376644746471167,0.013603279822988,0.000539331577647005
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30880.Urate,50312,0.0430353457641592,0.00299435983553285,0.0371664004865148,0.0489042910418036,1.26720183528041e-46
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30890.Vitamin D,49682,-0.00221708952565828,0.00270838804679237,-0.00752553009737133,0.00309135104605477,0.41302327265911
EPHA2,Ephrin type-A receptor 2,Physical measures,X3137.Number of measurements made,49086,0.00659766122660602,0.0485369591807252,-0.0885347787676153,0.101730101220827,0.89187742752714
EPHA2,Ephrin type-A receptor 2,Physical measures,X3143.Ankle spacing width,41474,0.0144791029981918,0.00435432599111503,0.0059446240556063,0.0230135819407772,0.000885949130786195
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41473,-0.0126923775531471,0.00317010020942312,-0.0189057739636164,-0.00647898114267776,6.26886718816474e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X3146.Speed of sound through heel,41474,-0.016673446536984,0.00306079849248258,-0.0226726115822498,-0.0106742814917181,5.20456187382069e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41474,-0.0155610803603548,0.00309020169673304,-0.0216178756859516,-0.00950428503475807,4.82749896736756e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X3148.Heel bone mineral density (BMD),41455,-0.0153248214361633,0.00310503723680755,-0.0214106944203061,-0.00923894845202055,8.09597790538302e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3526.Mother's age at death,42263,-0.00720463528195754,0.00319998950631195,-0.013476614714329,-0.00093265584958612,0.0243724972335813
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32824,0.00390122600920149,0.00535503774594282,-0.00659464797284644,0.0143970999912494,0.466338697140649
EPHA2,Ephrin type-A receptor 2,Physical measures,X4100.Ankle spacing width (left),35943,0.00515113871997381,0.00579959898112944,-0.0062160752830399,0.0165183527229875,0.374468307477118
EPHA2,Ephrin type-A receptor 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35941,-0.00853725608050307,0.00419626060211904,-0.0167619268606564,-0.000312585300349751,0.0419379428243563
EPHA2,Ephrin type-A receptor 2,Physical measures,X4103.Speed of sound through heel (left),35943,-0.0160529001369196,0.00401671227410435,-0.0239256561941642,-0.00818014407967512,6.49074147660156e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35943,-0.0137965461675327,0.00407251742757662,-0.0217786803255829,-0.00581441200948252,0.000708466658396793
EPHA2,Ephrin type-A receptor 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35934,-0.013192443214981,0.0040886707866481,-0.0212062379568112,-0.00517864847315069,0.00125827215954201
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35943,-0.0137890682173672,0.00407278155726261,-0.0217717200696019,-0.00580641636513249,0.00071378649106623
EPHA2,Ephrin type-A receptor 2,Physical measures,X4119.Ankle spacing width (right),35932,0.00806592298357056,0.00569200250115781,-0.00309040191869875,0.0192222478858399,0.156507159887882
EPHA2,Ephrin type-A receptor 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35931,-0.0125648622891658,0.00423321350199682,-0.0208619607530796,-0.00426776382525201,0.00300555329018133
EPHA2,Ephrin type-A receptor 2,Physical measures,X4122.Speed of sound through heel (right),35932,-0.0179248655955178,0.00401613661840017,-0.0257964933675821,-0.0100532378234534,8.1947412662172e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35932,-0.0163726619697792,0.00408514377639823,-0.0243795437715198,-0.00836578016803871,6.18797636237717e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35922,-0.0173682210083795,0.00410160142216556,-0.025407359795824,-0.00932908222093502,2.31865630370518e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35932,-0.0163723542001091,0.00408513692971977,-0.0243792225823599,-0.00836548581785837,6.18977015636411e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4194.Pulse rate,36306,0.0103093219686625,0.00381779524350675,0.00282644329138923,0.0177922006459357,0.00694212473015023
EPHA2,Ephrin type-A receptor 2,Physical measures,X4195.Pulse wave reflection index,36306,-0.01177970660331,0.0039839639344847,-0.0195882759149,-0.00397113729171997,0.00311812298924238
EPHA2,Ephrin type-A receptor 2,Physical measures,X4196.Pulse wave peak to peak time,36298,0.00671495581001104,0.00440397118907257,-0.00191682772057119,0.0153467393405933,0.127362503107239
EPHA2,Ephrin type-A receptor 2,Physical measures,X4198.Position of the pulse wave peak,36306,-0.00167992845761594,0.00477619990339401,-0.0110412802682682,0.00768142335303631,0.725051057412317
EPHA2,Ephrin type-A receptor 2,Physical measures,X4199.Position of pulse wave notch,36306,0.0121613043981447,0.00386176784318716,0.0045922394254979,0.0197303693707916,0.00164369142076954
EPHA2,Ephrin type-A receptor 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36306,0.0023588687555765,0.00486144880017329,-0.00716957089276315,0.0118873084039162,0.627534590654342
EPHA2,Ephrin type-A receptor 2,Physical measures,X4269.Number of triplets attempted (left),36092,0.120946763570647,0.190037379063366,-0.251526499393551,0.493420026534844,0.524511302150401
EPHA2,Ephrin type-A receptor 2,Physical measures,X4270.Volume level set by participant (left),36004,0.00030459441807195,0.0613942043477575,-0.120028046103533,0.120637234939677,0.996041613704501
EPHA2,Ephrin type-A receptor 2,Physical measures,X4276.Number of triplets attempted (right),36093,0.102237170382986,0.190428794379156,-0.27100326660016,0.475477607366132,0.591367348196652
EPHA2,Ephrin type-A receptor 2,Physical measures,X4277.Volume level set by participant (right),36010,0.0897551391123595,0.0609688652399425,-0.0297438367579278,0.209254114982647,0.141023640988667
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4288.Time to answer,36270,-0.000424045507019579,0.00453355567231666,-0.00930981462476023,0.00846172361072107,0.925481097774229
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4290.Duration screen displayed,36270,0.016016809938302,0.00424255257258577,0.00770140689603389,0.0243322129805701,0.000161036713406798
EPHA2,Ephrin type-A receptor 2,Physical measures,X46.Hand grip strength (left),51320,-0.0413372678872613,0.00315383348539464,-0.0475187815186348,-0.0351557542558878,4.16371302375149e-39
EPHA2,Ephrin type-A receptor 2,Physical measures,X47.Hand grip strength (right),51319,-0.040082002552921,0.00310907315248404,-0.0461757859317897,-0.0339882191740523,6.78627894124763e-38
EPHA2,Ephrin type-A receptor 2,Physical measures,X48.Waist circumference,51378,0.0356696001431019,0.00589689913584544,0.0241116778368448,0.0472275224493589,1.48135838488501e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X4803.Tinnitus,36127,0.0750256444903446,0.0685674706997678,-0.0593665980812003,0.20941788706189,0.273907938932485
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4825.Noisy workplace,36204,0.053462380408495,0.0663615508728705,-0.0766062593023313,0.183531020119321,0.420485555786082
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4836.Loud music exposure frequency,36161,0.00494511911407262,0.0921228459163075,-0.17561565888189,0.185505897110035,0.957191840956962
EPHA2,Ephrin type-A receptor 2,Physical measures,X49.Hip circumference,51372,0.000434805376414715,0.00436909190485498,-0.00812861475710104,0.00899822550993047,0.920727493451636
EPHA2,Ephrin type-A receptor 2,Physical measures,X50.Standing height,51331,0.0128065504035214,0.00331022013081647,0.00631851894712109,0.0192945818599217,0.000109681292857259
EPHA2,Ephrin type-A receptor 2,Health and medical history,X5057.Number of older siblings,35295,0.0320608688739348,0.0657027618222861,-0.096716544297746,0.160838282045616,0.62558823503352
EPHA2,Ephrin type-A receptor 2,Physical measures,X51.Seated height,51244,0.00299944300509611,0.00288520425155608,-0.0026555573279538,0.00865444333814601,0.298539347292047
EPHA2,Ephrin type-A receptor 2,Eye measures,X5181.Ever had eye surgery,33777,0.407368907951639,0.137098277880318,0.138656283306216,0.676081532597063,0.00297843851465821
EPHA2,Ephrin type-A receptor 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33766,0.00991197471599442,0.00492697612852116,0.000255101504092954,0.0195688479278959,0.0442953306056015
EPHA2,Ephrin type-A receptor 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33761,0.0129308605618634,0.00507007978289636,0.00299350418738651,0.0228682169363403,0.010787784766748
EPHA2,Ephrin type-A receptor 2,Eye measures,X5190.Duration at which refractometer first shown (right),33714,0.0080831732209883,0.00507016371599286,-0.00185434766235771,0.0180206941043343,0.110938989695964
EPHA2,Ephrin type-A receptor 2,Eye measures,X5193.Duration at which refractometer first shown (left),33709,0.015931929688763,0.00509109542213235,0.00595338266138356,0.0259104767161424,0.00176167575243202
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5199.logMAR, initial (right)",33744,0.115216298979397,0.078007886349501,-0.0376791582656252,0.268111756224419,0.139741501156477
EPHA2,Ephrin type-A receptor 2,Eye measures,X5200.Final number of letters displayed (right),33744,-0.307235403086803,0.418448170441486,-1.12739381715211,0.512923010978509,0.462844667636872
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5201.logMAR, final (right)",33684,0.010229183112929,0.00487165330333951,0.000680742638383589,0.0197776235874745,0.0358012821249957
EPHA2,Ephrin type-A receptor 2,Eye measures,X5202.Number of rounds to result (right),33744,-0.0608711775221396,0.0738189458999166,-0.205556311485976,0.083813956441697,0.40963646263343
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5206.logMAR, initial (left)",33739,0.0554332958777553,0.0776576746180685,-0.0967757463736588,0.207642338129169,0.47537334623445
EPHA2,Ephrin type-A receptor 2,Eye measures,X5207.Final number of letters displayed (left),33739,0.297735192728581,0.463076325256239,-0.609894404773649,1.20536479023081,0.520284863070355
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5208.logMAR, final (left)",33693,0.0076237002649281,0.00490880251979537,-0.00199755267387083,0.017244953203727,0.120469211430238
EPHA2,Ephrin type-A receptor 2,Eye measures,X5209.Number of rounds to result (left),33736,-0.057145831975584,0.0728986419654006,-0.200027170227769,0.0857355062766012,0.433130295549306
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33547,-0.0132628878042354,0.00482729826840899,-0.022724392410317,-0.00380138319815374,0.00602733957090611
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33547,-0.0137319148215771,0.0047422646504808,-0.0230267535365195,-0.00443707610663476,0.00380037723362537
EPHA2,Ephrin type-A receptor 2,Eye measures,X5256.Corneal hysteresis (right),33547,0.00131417790717508,0.00493556318644117,-0.00835952593824961,0.0109878817525998,0.790044635459432
EPHA2,Ephrin type-A receptor 2,Eye measures,X5257.Corneal resistance factor (right),33547,-0.00682179014170955,0.00486941878301454,-0.016365850956418,0.00272227067299894,0.161293106990087
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33522,-0.0154259667717493,0.00487801018483403,-0.024986866734024,-0.00586506680947464,0.0015745365077699
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33522,-0.0170053561820907,0.00482472501711941,-0.0264618172156447,-0.00754889514853662,0.000427937260597712
EPHA2,Ephrin type-A receptor 2,Eye measures,X5264.Corneal hysteresis (left),33522,0.00186232060595486,0.00487787558111754,-0.00769831553303552,0.0114229567449453,0.702634152223703
EPHA2,Ephrin type-A receptor 2,Eye measures,X5265.Corneal resistance factor (left),33522,-0.00703693751660921,0.00485593191920821,-0.0165545640782573,0.00248068904503889,0.147361486239453
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34393,0.65822199819072,0.324786595193554,0.0216402716113545,1.29480372477009,0.0427460754323571
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51324,0.0333493074997809,0.0128641429407565,0.00813558733589819,0.0585630276636637,0.00953633672905758
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51324,0.0436352171421273,0.0149972543739732,0.0142405985691399,0.0730298357151148,0.00362303835586629
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51324,0.107908030827327,0.0365814493915175,0.0362083900199527,0.179607671634701,0.00318301775757895
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51324,-0.0147192915713018,0.00589490198490872,-0.0262732994617229,-0.00316528368088073,0.0125335867881007
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51324,-0.00110190548746707,0.00546549160797762,-0.0118142690391032,0.00961045806416907,0.840222326546249
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38562,-0.0418888454193108,0.00736394981141392,-0.0563221870496821,-0.0274555037889396,1.31878573977266e-08
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38562,-0.00800893197963333,0.0228883225383505,-0.0528700441548004,0.0368521801955337,0.726411047397621
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38562,-0.0412571905767089,0.0142233625275532,-0.0691349811307131,-0.0133794000227047,0.00373188041289242
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38562,0.00501947877235384,0.00857495449460935,-0.0117874320370805,0.0218263895817882,0.558315534535464
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51382,0.0262202369494748,0.0125073032522817,0.00170592257500271,0.0507345513239468,0.0360582446566561
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51382,0.0262202369494748,0.0125073032522817,0.00170592257500271,0.0507345513239468,0.0360582446566561
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51382,-0.0123805457936472,0.0090594155726105,-0.0301370003159638,0.00537590872866935,0.171765987491496
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51382,-0.029634737286633,0.0159417768222203,-0.0608806198581849,0.00161114528491886,0.0630491448860987
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51382,0.00435525811695646,0.0376464198285704,-0.0694317247470415,0.0781422409809544,0.907900434530757
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51382,0.0162432897636356,0.0266851612215498,-0.036059626230602,0.0685462057578732,0.542728577851145
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51382,0.0477431676617173,0.0395485709352304,-0.0297720313713343,0.125258366694769,0.227366370801368
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51323,-0.00525973235440419,0.00807310956341742,-0.0210830270987023,0.010563562389894,0.514722254854295
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51323,0.0397355805853883,0.01417432143178,0.0119539105790994,0.0675172505916772,0.00506176485822566
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51323,-0.0185931551672026,0.00739260652005888,-0.033082663946518,-0.00410364638788719,0.011906657679678
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51323,0.0313557756271331,0.0109008888231518,0.00999003353375558,0.0527215177205106,0.00402560052076963
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51323,0.0146305053034437,0.0110577690349684,-0.0070427220050944,0.0363037326119818,0.185816307434873
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51323,0.0521844718401693,0.0062088543421705,0.0400151173295151,0.0643538263508235,4.53245212177562e-17
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,36829,0.0256582341119824,0.0135888384552842,-0.000975889260374591,0.0522923574843395,0.0590363318929144
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,36829,-0.0127522442117123,0.0129227175803091,-0.0380807706691181,0.0125762822456934,0.323765667024274
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,36829,0.0953390741812756,0.0187412111791951,0.0586063002700532,0.132071848092498,3.71543181839556e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,36829,0.0435121247124384,0.0139555424658822,0.0161592614793093,0.0708649879455674,0.00182766645279322
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51258,-0.00153904057688379,0.0217331835175577,-0.0441360802712969,0.0410579991175293,0.94354542858467
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51258,0.0344911692994071,0.0269096494929548,-0.0182517437067843,0.0872340823055985,0.199947046765485
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51258,0.0782011343426979,0.0530626501513806,-0.0258016599540081,0.182203928639404,0.140562534860552
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51258,0.0553783786423094,0.0507322512857219,-0.0440568338777056,0.154813591162324,0.27502877033919
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51258,0.0207360102793861,0.0206117650274318,-0.0196630491743802,0.0611350697331523,0.314412902101886
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51258,0.0454282265709295,0.024265584681079,-0.00213231940398544,0.0929887725458444,0.0612020754906143
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51258,0.00621479854316503,0.0102314606792836,-0.0138388643882309,0.0262684614745609,0.543578001571251
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35405,0.115798696380115,0.0173380438758464,0.0818161303834562,0.149781262376774,2.59794305967664e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35405,0.078880552332996,0.0170581954375248,0.0454464892754474,0.112314615390545,3.82988978489513e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35405,0.163071803169502,0.0242424633563207,0.115556574991114,0.210587031347891,1.8766349247353e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35405,0.00234924815800547,0.00875344536567907,-0.0148075047587255,0.0195060010747365,0.788415100413255
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38457,0.00831535273598117,0.00816041983194893,-0.00767907013463873,0.0243097756066011,0.308234670149092
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38457,-0.022256980295266,0.00903839654325471,-0.0399722375200452,-0.00454172307048674,0.0138144988287501
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38457,0.0129604981736642,0.00800351563141131,-0.00272639246390194,0.0286473888112304,0.105403831549859
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38458,0.0389937968019733,0.0187322937602295,0.0022785010319235,0.0757090925720232,0.0374015671207588
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38458,0.073721810856397,0.0111243998239865,0.0519179872013835,0.0955256345114104,3.60400750995049e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38458,0.0837638290742269,0.0199155437747643,0.0447293632756889,0.122798294872765,2.62284438448854e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51323,-0.00110872221731878,0.0160400266686388,-0.0325471744878508,0.0303297300532132,0.94489294427743
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51323,0.040800409928435,0.0129293808030349,0.0154588235544866,0.0661419963023833,0.00160357938881557
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51323,0.0697040925802434,0.0258386577472296,0.0190603233956734,0.120347861764813,0.0069878800018622
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51323,0.0193566838341443,0.014426625057837,-0.00891950127921616,0.0476328689475047,0.179695880226821
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51323,0.00222465839475223,0.0148634973076915,-0.0269077963283231,0.0313571131178276,0.881024249297617
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51323,0.095336061050769,0.0178415510548223,0.0603666209833174,0.130305501118221,9.20541563536562e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51323,-0.00382074414190739,0.00517084874786477,-0.0139556076877223,0.00631411940390755,0.459974884401506
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33962,0.0845544015397335,0.0134616445944781,0.0581695781345565,0.11093922494491,3.62594658359012e-10
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33962,0.0928773040815891,0.0160877998311723,0.0613452164124913,0.124409391750687,8.21718401370832e-09
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33962,-0.0873703908553724,0.0119510124241051,-0.110794375206618,-0.0639464065041264,3.04819149871661e-13
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33962,0.0110762896134956,0.010687847235936,-0.00987189096893891,0.0320244701959301,0.300088277266909
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51414,0.0225583620413855,0.00627804906388897,0.0102533858761631,0.0348633382066079,0.000327313847400195
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51414,0.0604816421645319,0.0206849761625134,0.0199390888860057,0.101024195443058,0.00345970485558169
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51414,0.00743117468705248,0.00552602448634514,-0.003399833306184,0.018262182680289,0.178716237208159
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51414,0.00376751824314555,0.00516687723827341,-0.00635956114387034,0.0138945976301614,0.465906778980211
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51414,0.0557596832351969,0.00877041619678212,0.038569667489504,0.0729496989808899,2.08673585112859e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51414,0.0423319162790368,0.00790081812401781,0.0268463127559619,0.0578175198021117,8.50033504998209e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51414,0.0152243029747734,0.00557061157034349,0.00430590429690018,0.0261427016526467,0.00628147791727545
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51414,0.111665576216128,0.018021237642466,0.0763439504368952,0.146987201995362,5.87830458191928e-10
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44469,-0.0190262476651938,0.00561920266732033,-0.0300398848931417,-0.00801261043724597,0.000711085147440135
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44469,-0.0404058800095279,0.00552096014617838,-0.0512269618960375,-0.0295847981230183,2.62503842354083e-13
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44469,0.0374505965658901,0.0071482254815494,0.0234400746220533,0.0514611185097269,1.63384540090337e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44470,0.0104502670718825,0.011125452425635,-0.0113556196823621,0.0322561538261271,0.34758505480288
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44470,0.0128223984653391,0.0063263883777909,0.000422677244868974,0.0252221196858093,0.042698351418366
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51209,-0.0187098718527149,0.00589616904626341,-0.0302663631833911,-0.0071533805220386,0.00150957339375031
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51209,-0.0197394060048754,0.00463947131835203,-0.0288327697888454,-0.0106460422209054,2.10202334443239e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51209,0.0176148996890968,0.00523642448698131,0.00735150769461341,0.0278782916835801,0.000769721417984667
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51209,-0.0171875118075509,0.0080202389391981,-0.0329071801283792,-0.00146784348672266,0.0321223404395118
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51231,-0.0435693945226493,0.00498898573984825,-0.0533478065727519,-0.0337909824725467,2.64595305867492e-18
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51231,-0.00576047258399754,0.00697652422208377,-0.0194344600592817,0.00791351489128665,0.408986531312814
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51323,-0.0289985864981187,0.00512484369551364,-0.0390432801413254,-0.0189538928549119,1.5459952614862e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51323,-0.0260159261377009,0.00643070421601012,-0.0386201064010807,-0.013411745874321,5.2366254768726e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51323,0.0434683151339407,0.0137415148658157,0.0165349459969419,0.0704016842709395,0.00156205381882796
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51323,-0.0174222806236182,0.012577803776057,-0.0420747760246898,0.00723021477745349,0.166016904532069
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51323,0.0643353306923191,0.0152457755805404,0.0344536105544599,0.0942170508301782,2.45381365037678e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51323,-0.0331329380218636,0.015791083008849,-0.0640834607192077,-0.00218241532451944,0.0358980039751095
EPHA2,Ephrin type-A receptor 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41474,-0.0155591126098516,0.00309021715514429,-0.0216159382339344,-0.00950228698576879,4.84417794089133e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X864.Number of days or week walked 10+ minutes,50952,-0.17607888698074,0.0358967324248157,-0.246436482533379,-0.105721291428101,9.40115140975078e-07
EPHA2,Ephrin type-A receptor 2,Physical activities,X874.Duration of walks,48403,-0.00123041251777693,0.00236421263675206,-0.00586426928581098,0.00340344425025711,0.602768150753646
EPHA2,Ephrin type-A receptor 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50381,-0.203245885331636,0.0348836497816813,-0.271617838903732,-0.134873931759541,5.74355687653458e-09
EPHA2,Ephrin type-A receptor 2,Physical activities,X894.Duration of moderate activity,45756,0.0594057744128011,0.0426180427185325,-0.0241255893155227,0.142937138141125,0.163362424461802
EPHA2,Ephrin type-A receptor 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33144,-0.0165156944715651,0.00498479745695953,-0.0262858974872058,-0.00674549145592442,0.000929525069183391
EPHA2,Ephrin type-A receptor 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50305,-0.262953402930935,0.0359882767145164,-0.333490425291387,-0.192416380570483,2.8337748820391e-13
EPHA2,Ephrin type-A receptor 2,Physical activities,X914.Duration of vigorous activity,41590,0.0049537077819366,0.0026664914281141,-0.000272615417167036,0.0101800309810402,0.0632253593967915
